SLE (Finngen)

SLE_FG

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints SLE_OTH SLE_NOS M13_SLE	1546
6. Filter based on genotype QC (FinnGen only)	1385

Control definitions (FinnGen only)

Control exclude: AUTOIMMUNE

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	SLE_FG
CONTROL_EXCLUDE	AUTOIMMUNE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	SLE_OTH\|SLE_NOS\|M13_SLE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to SLE (Finngen) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1385	1137	248
Unadjusted period prevalence (%)	0.35	0.40	0.11
Median age at first event (years)	45.82	44.00	54.16

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1442: Matched controls
14420

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

16.3

307.7

304

232

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

30.1

307.7

448

213

P01BA02

ATC

hydroxychloroquine; oral

182.3

307.7

1046

206

L93.0

ICD-10 Finland

Discoid lupus erythematosus

175.6

307.7

184

L04AX03

ATC

methotrexate; systemic

34.5

307.7

471

200

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

192.8

307.7

185

L04AA06

ATC

mycophenolic acid; systemic

80.8

307.7

270

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

16384.0

307.7

1164

L04AX01

ATC

azathioprine; systemic

143.3

307.7

411

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

128.7

307.7

305

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

141.2

307.7

991

221

L88

ICPC

Rheumatoid/seropositive arthritis

39.0

307.7

205

L01BA01

ATC

methotrexate; systemic

110.9

307.7

184

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

156.6

307.7

225

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

+∞

307.7

335

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

6.6

276.9

928

3102

H02AB06

ATC

prednisolone; systemic

7.8

273.1

1125

4506

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

+∞

262.8

244

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

+∞

255.0

237

H02AB07

ATC

prednisone; oral

7.2

244.7

459

880

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

9.2

235.7

326

444

H03AA01

ATC

levothyroxine sodium; systemic

8.1

225.0

351

549

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

15.1

224.7

209

160

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

7.3

195.4

331

562

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

+∞

193.2

181

M32

ICD-10 Finland

Systemic lupus erythematosus

+∞

189.9

178

M05BA04

ATC

alendronic acid; oral

6.5

170.9

327

624

L04AD01

ATC

ciclosporin; systemic

30.5

165.4

110

XX9XE

NOMESCO Finland

Other ultrasound examination

84.1

164.0

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

+∞

156.1

147

L04AA01

ATC

[U] ciclosporin

52.6

154.9

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

55.1

154.6

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.2

153.8

936

4377

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

+∞

142.1

134

L04AA13

ATC

[U] leflunomide

52.7

130.6

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

23.0

129.3

A07EC01

ATC

sulfasalazine; oral, rectal

10.0

128.9

154

170

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

26.3

127.5

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

5.7

127.0

271

565

M35.1

ICD-10 Finland

Other overlap syndromes

1188.7

114.2

110

C08CA05

ATC

nifedipine; systemic

6.7

112.1

194

329

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

26.8

107.1

R50.9

ICD-10 Finland

Fever, unspecified

3.9

101.9

375

1190

ZX120

NOMESCO Finland

Intravenous

4.8

97.0

247

593

H02AB04

ATC

methylprednisolone; systemic

3.9

96.4

354

1118

C03CA01

ATC

furosemide; systemic

3.3

94.7

524

2146

D68.8

ICD-10 Finland

Other specified coagulation defects

15.5

92.7

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.7

92.1

240

586

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

23.8

91.4

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.1

89.9

564

2471

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

15.1

88.4

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.9

87.9

310

947

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

6.5

83.2

143

239

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.3

81.3

382

1401

K90.0

ICD-10 Finland

Coeliac disease

19.0

78.1

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

10.4

75.2

M13.9

ICD-10 Finland

Arthritis, unspecified

4.7

70.6

179

424

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

14.4

67.6

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.8

67.5

446

1961

TPH04

NOMESCO Finland

Cathetrisation of vein

2.9

67.2

421

1799

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

13.7

66.8

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.8

66.6

233

700

J01MA12

ATC

levofloxacin; systemic

3.0

65.1

352

1384

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

25.0

65.0

E0000UV, ,

ATC

2.5

64.5

749

4317

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.7

63.8

229

699

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

18.1

60.4

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

86.5

59.5

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.4

58.3

771

4645

D07AB08

ATC

desonide; topical

3.4

58.3

241

804

A02BC02

ATC

pantoprazole; systemic

2.8

58.2

1115

7954

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.9

57.9

332

1340

J01FF01

ATC

clindamycin; systemic

2.5

56.6

487

2409

H04.10

ICD-10 Finland

Dry eye syndrome

3.1

55.9

282

1058

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

73.0

55.6

104

Kela drug reimbursment

Thyroid insufficiency

6.1

55.3

100

175

NH3EA

NOMESCO Finland

Feet X-ray examination with load

11.4

54.9

Z94.0

ICD-10 Finland

Kidney transplant status

21.6

53.4

M79.0

ICD-10 Finland

Rheumatism, unspecified

5.8

52.9

101

186

SBA10

NOMESCO Finland

Measurement of salivary flow rate

14.3

51.2

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

9.5

50.7

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.6

50.5

392

1833

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

5.7

50.1

181

B01AA03

ATC

warfarin; systemic

2.9

50.0

281

1114

G05.8*M32.1

ICD-10 Finland

Encephalitis in systemic lupus erythematosus

+∞

48.2

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

+∞

48.2

D07AC01

ATC

betamethasone; topical

2.3

48.0

604

3479

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.7

47.9

116

263

N18.0

ICD-10 Finland

End-stage renal disease

20.0

47.7

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

7.6

47.3

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

248.1

47.3

N02AX02

ATC

tramadol; systemic, rectal

2.2

47.0

681

4146

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

4.2

46.7

132

338

P01BA01

ATC

chloroquine; systemic

68.6

46.4

R4120

NOMESCO Finland

Occupational therapy

3.8

46.0

151

430

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

4.3

45.3

123

305

127

Kela drug reimbursment

Transplant complication

12.2

44.7

TNG10

NOMESCO Finland

Puncture of knee

17.2

44.6

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

451.1

44.5

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

9.3

44.4

UJF30

NOMESCO Finland

Ileoscopy through colon

3.1

44.3

205

726

L93.1

ICD-10 Finland

Subacute cutaneous lupus erythematosus

158.3

44.0

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.2

44.0

196

679

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

+∞

44.0

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

43.8

411

2077

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

17.6

43.8

M05BA07

ATC

risedronic acid; oral

5.4

42.4

171

E03

ICD-10 Finland

Other hypothyroidism

8.0

42.3

M05BX04

ATC

denosumab; parenteral

3.7

42.3

145

425

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.9

42.2

227

874

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.4

42.2

390

1954

L40.0

ICD-10 Finland

Psoriasis vulgaris

11.6

41.5

A07EA06

ATC

budesonide; oral, local oral

8.2

41.1

Z49.1

ICD-10 Finland

Extracorporeal dialysis

12.8

41.0

A11CC03

ATC

alfacalcidol; systemic

7.2

40.9

I73.0

ICD-10 Finland

Raynaud syndrome

7.1

40.5

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

4.2

40.5

113

286

R06.0

ICD-10 Finland

Dyspnoea

2.2

40.4

448

2417

J01MA02

ATC

ciprofloxacin; systemic

2.1

40.3

591

3556

L99

ICPC

Musculoskeletal disease other

6.3

40.3

114

WZA10

NOMESCO Finland

Extensive medical or dental certificate

10.1

39.3

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.4

39.3

152

482

A07EC02

ATC

mesalazine; oral, rectal

8.3

39.0

M05BB03

ATC

alendronic acid and colecalciferol; oral

6.1

38.9

118

KA1AE

NOMESCO Finland

Kidney ultrasound examination

6.8

38.9

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.7

38.7

247

1037

E03.89

ICD-10 Finland

Other specified hypothyroidism

7.9

38.4

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

4.4

38.4

100

240

XF400

NOMESCO Finland

ECG with 12 standard connections

2.6

38.4

254

1086

TK800

NOMESCO Finland

Hemodialysis

9.1

38.2

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

387.3

38.2

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

7.1

37.9

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.5

37.7

226

B07.9

ICD-10 Finland

Verruca simplex

4.5

37.5

227

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

13.8

37.5

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.0

36.9

181

660

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

+∞

36.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.4

36.5

319

1548

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.9

36.4

113

309

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

36.3

654

4201

Z3231

NOMESCO Finland

Registered nurse

2.2

36.2

433

2391

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

70.2

36.1

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

4.7

35.9

189

A46

ICD-10 Finland

Erysipelas

2.7

35.8

226

942

Z3229

NOMESCO Finland

Other healthcare associate professional

3.3

35.6

146

479

UJF32

NOMESCO Finland

Coloscopy

2.2

35.3

386

2053

D07AD01

ATC

clobetasol; topical

2.4

35.3

290

1367

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

8.9

35.0

M79.7

ICD-10 Finland

Fibromyalgia

4.3

34.8

223

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

5.4

34.5

136

B01AB05

ATC

enoxaparin; parenteral

2.0

34.4

508

3024

E000001, ,

ATC

2.3

34.4

337

1713

A02BC01

ATC

omeprazole; systemic

2.1

34.3

439

2480

XW000

NOMESCO Finland

Bone marrow biopsy

4.5

33.8

198

R4110

NOMESCO Finland

Physiotherapy

2.1

33.5

459

2655

G73.7*M32.1

ICD-10 Finland

Myopathy in systemic lupus erythematosus

+∞

33.5

A02BC03

ATC

lansoprazole; oral

2.1

33.4

458

2649

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

5.1

33.4

144

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.1

33.1

148

511

NF1AA

NOMESCO Finland

Hip X-ray examination

2.9

32.9

167

620

H26.3

ICD-10 Finland

Drug-induced cataract

38.3

32.6

B03XA02

ATC

darbepoetin alfa; parenteral

7.3

32.3

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.3

32.1

127

407

GD1AD

NOMESCO Finland

Thorax CT examination

3.4

32.0

122

382

C08CA02

ATC

felodipine; oral

3.0

32.0

158

577

M01CB01

ATC

sodium aurothiomalate; parenteral

323.9

32.0

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

31.8

243

1105

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

5.2

31.7

135

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

3.9

31.7

253

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

48.7

31.7

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.8

31.6

102

286

XPX04

NOMESCO Finland

Angioscopy

54.2

31.4

J01FA06

ATC

roxithromycin; oral

1.9

31.4

637

4201

Z2221

NOMESCO Finland

Medical doctor

2.0

31.2

456

2688

D07AC13

ATC

mometasone; topical

2.0

31.2

457

2696

D64.9

ICD-10 Finland

Anaemia, unspecified

2.8

30.8

168

647

L28

ICPC

Limited function/disability (L)

2.2

30.7

307

1565

XQ848

NOMESCO Finland

Dermatological photography

4.9

30.6

143

A12AA04

ATC

calcium carbonate; oral

9.2

30.4

J05AB11

ATC

valaciclovir; oral

2.3

30.4

276

1352

Z3226

NOMESCO Finland

Physiotherapist

2.2

30.3

302

1537

N18.8

ICD-10 Finland

Other chronic renal failure

7.1

29.8

D70.89

ICD-10 Finland

Neutropenic splenomegaly

7.5

29.8

J05AB01

ATC

aciclovir; systemic

2.0

29.7

392

2222

A07AA02

ATC

nystatin; oral

3.3

29.4

117

376

N03AX16

ATC

[U] pregabalin

2.1

29.3

359

1978

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.1

29.2

132

458

1XC02, ,

NOMESCO Finland

28.6

29.0

L01AA01

ATC

cyclophosphamide; systemic

81.9

28.8

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.9

28.7

146

541

D07AB02

ATC

hydrocortisone butyrate; topical

1.9

28.2

475

2920

L93.2

ICD-10 Finland

Other local lupus erythematosus

+∞

28.2

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

8.9

28.1

L04AB01

ATC

etanercept; parenteral

27.8

28.1

C08CA01

ATC

amlodipine; oral

1.9

28.0

543

3495

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

27.8

191

824

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

26.0

27.6

H02AB09

ATC

hydrocortisone; systemic

5.8

27.5

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

35.8

27.5

TGC00

NOMESCO Finland

Bronchial lavation

5.5

27.4

102

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.8

27.3

147

561

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.2

27.2

179

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

+∞

27.2

S97

ICPC

Chronic ulcer skin

3.4

27.2

100

306

WW200

NOMESCO Finland

Immunization

5.2

27.0

111

M81.9

ICD-10 Finland

Osteoporosis, unspecified

3.3

26.9

105

333

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

26.9

256

1274

A10AB05

ATC

insulin aspart; parenteral

3.8

26.9

235

N03AX12

ATC

[U] gabapentin; oral

2.2

26.7

258

1292

M25.5

ICD-10 Finland

Pain in joint

1.9

26.6

549

3591

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.7

26.3

159

644

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

3.3

26.3

104

333

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

6.4

26.3

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

26.2

163

670

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

6.8

26.0

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.6

26.0

158

642

J01DB01

ATC

cefalexin; oral

2.2

25.9

1220

10296

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

4.1

25.8

186

M35.3

ICD-10 Finland

Polymyalgia rheumatica

3.8

25.8

218

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.3

25.7

208

966

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

5.3

25.6

101

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.6

25.6

166

696

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

6.2

25.6

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.1

25.5

111

376

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

5.1

25.5

109

L95

ICPC

Osteoporosis

3.5

25.5

278

L04AD02

ATC

tacrolimus; systemic

10.6

25.4

A10AB01

ATC

insulin (human); parenteral

10.6

25.4

L84

ICD-10 Finland

Corns and callosities

4.0

25.4

193

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

25.4

579

3891

I50.9

ICD-10 Finland

Heart failure, unspecified

2.5

25.3

172

738

B99

ICD-10 Finland

Other and unspecified infectious diseases

5.8

25.2

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

+∞

25.1

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

+∞

25.1

H20.1

ICD-10 Finland

Chronic iridocyclitis

+∞

25.1

M13.0

ICD-10 Finland

Polyarthritis, unspecified

9.8

25.1

TAB00

NOMESCO Finland

Lumbar puncture

3.5

25.0

276

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

26.7

24.9

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

71.2

24.9

A02BC05

ATC

esomeprazole; systemic

1.8

24.8

617

4247

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

24.8

421

2577

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

4.1

24.8

174

C07AB07

ATC

bisoprolol; oral

1.8

24.8

650

4544

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.3

24.7

314

T86

ICPC

Hypothyroidism/myxoedema

5.7

24.5

N06AA09

ATC

amitriptyline; systemic

2.5

24.4

166

712

J01MA14

ATC

moxifloxacin; systemic

2.6

24.3

148

601

AA1AD

NOMESCO Finland

CT of head and brain

1.9

24.3

408

2485

107

Kela drug reimbursment

Pernicious anaemia

+∞

24.0

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.7

23.9

140

558

A01

ICPC

Pain general/multiple sites

2.4

23.9

188

861

Z2446

NOMESCO Finland

Social worker

2.9

23.7

119

437

L04AB04

ATC

adalimumab; parenteral

19.9

23.5

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.2

23.2

326

M05BA06

ATC

ibandronic acid; systemic

4.6

23.0

123

M34.1

ICD-10 Finland

CR(E)ST syndrome

+∞

23.0

WZC00

NOMESCO Finland

Treatment plan or consultation

1.8

22.9

563

3837

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

3.7

22.9

203

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.3

22.9

185

857

K51.5

ICD-10 Finland

Left sided colitis

84.8

22.7

TQW80

NOMESCO Finland

Local dermatologic skincare

4.8

22.5

109

M01AH02

ATC

rofecoxib; oral

2.3

22.5

198

950

J01DA01

ATC

[U] cefalexin

1.8

22.5

911

7128

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.9

22.3

174

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

21.8

22.2

M31.3

ICD-10 Finland

Wegener granulomatosis

+∞

21.9

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

21.8

601

4215

A02BA02

ATC

ranitidine; systemic

2.0

21.8

283

1575

318

Kela drug reimbursment

Teriparatide

20.4

21.7

L40.5

ICD-10 Finland

Arthropathic psoriasis

223.2

21.7

J02AC01

ATC

fluconazole; systemic

1.7

21.6

668

4832

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.1

21.6

151

N02AA05

ATC

oxycodone; systemic

2.0

21.6

258

1393

JN4AD

NOMESCO Finland

Body CT examination

2.3

21.4

174

806

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

44.0

21.4

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

21.4

207

1031

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.6

21.2

204

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.9

21.1

100

356

137

Kela drug reimbursment

Uraemia requiring dialysis

24.6

20.9

N32.9

ICD-10 Finland

Bladder disorder, unspecified

24.6

20.9

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

+∞

20.9

M34.0

ICD-10 Finland

Progressive systemic sclerosis

+∞

20.9

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.9

20.8

73491

ICD-8 Finland

Diffuse diseases of connective tissue, Collagenosis NUD

213.0

20.6

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.3

20.6

164

753

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

4.5

20.2

115

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.7

20.2

110

422

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

5.9

20.2

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.5

20.1

133

562

WX002

NOMESCO Finland

Sedation and analgesia

1.9

19.9

279

1590

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

19.9

279

1590

N16.4*M32.1

ICD-10 Finland

Renal tubulo-interstitial disorders in systemic lupus erythematosus

+∞

19.8

I32.8*M32.1

ICD-10 Finland

Pericarditis (in) systemic lupus erythematosus

+∞

19.8

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

4.4

19.8

117

R51.80

ICD-10 Finland

Headache

1.9

19.7

269

1518

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

6.5

19.7

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

19.6

219

1150

ZX108

NOMESCO Finland

Inhalation

14.8

19.4

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

19.3

627

4555

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

4.8

19.2

H05AA02

ATC

teriparatide; parenteral

20.4

19.1

B02.9

ICD-10 Finland

Zoster without complication

2.5

19.1

124

519

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

34.8

18.9

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

5.1

18.8

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.4

18.8

109

C02DE02, ,

ATC

8.2

18.8

TEA00

NOMESCO Finland

Biopsy of lip

8.2

18.8

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

+∞

18.8

N08.5*M31.1

ICD-10 Finland

Glomerular disorders in thrombotic thrombocytopenic purpura

+∞

18.8

J01AA02

ATC

doxycycline; systemic

1.8

18.8

1130

9613

T89

ICPC

Diabetes insulin dependent

6.0

18.7

C02CA01

ATC

prazosin; oral

7.1

18.7

A10AB04

ATC

insulin lispro; parenteral

7.4

18.7

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.2

18.7

237

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

24.0

18.7

A12BA01

ATC

potassium chloride; oral

3.5

18.6

197

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

101.4

18.6

D02AX

ATC

Other emollients and protectives

3.6

18.6

173

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

18.6

445

2973

7109X

ICD-9 Finland

Diffuse diseases of connective tissue, Unspecified diffuse connective tissue disease

192.4

18.6

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.7

18.5

103

399

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

18.5

256

1449

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

18.4

171

836

M81.4

ICD-10 Finland

Drug-induced osteoporosis

30.5

18.4

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.8

18.4

151

S01BA04

ATC

prednisolone; ophthalmic

5.0

18.4

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.1

18.3

129

B05DA

ATC

Isotonic solutions

25.4

18.2

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.9

18.2

317

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

18.0

151

708

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.1

18.0

126

NH3AE

NOMESCO Finland

Feet ultrasound examination

53.2

18.0

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

17.9

258

1478

A01AB09

ATC

miconazole; local oral

2.4

17.9

134

598

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.0

17.9

292

Z49.2

ICD-10 Finland

Other dialysis

27.1

17.8

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.2

17.8

223

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

17.8

192

994

M31.1

ICD-10 Finland

Thrombotic microangiopathy

+∞

17.7

6BA02, ,

NOMESCO Finland

37.2

17.6

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.5

17.6

120

514

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

182.1

17.5

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

17.5

497

3462

C09AA02

ATC

enalapril; systemic

1.9

17.4

242

1370

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

17.4

143

665

A01AC01

ATC

triamcinolone; local oral

5.4

17.4

Z49.0

ICD-10 Finland

Preparatory care for dialysis

15.0

17.2

A41.9

ICD-10 Finland

Sepsis, unspecified

3.7

17.1

154

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

17.1

152

730

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

6.9

17.0

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

7.3

17.0

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

17.6

16.9

WX892

NOMESCO Finland

Monitored bed care

2.5

16.9

107

442

SPAT1263

SPAT

Sampling

1.6

16.9

577

4202

WX203

NOMESCO Finland

Infraclavicular plexus blockade

4.0

16.9

123

A10AC01

ATC

insulin (human); parenteral

3.0

16.8

274

C03DA01

ATC

spironolactone; oral

2.1

16.8

163

810

XCK00

NOMESCO Finland

Perimetry

2.7

16.8

348

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.9

16.8

223

1243

R13

ICD-10 Finland

Dysphagia

2.5

16.7

110

463

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

5.5

16.7

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

+∞

16.7

P01AB01

ATC

metronidazole; oral, rectal

1.6

16.7

611

4523

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.4

16.7

186

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

12.8

16.7

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

91.1

16.6

N02BE01

ATC

paracetamol; systemic, rectal

2.1

16.5

1296

11651

R06AE07

ATC

cetirizine; oral

1.6

16.5

668

5059

B05DB

ATC

Hypertonic solutions

23.3

16.4

N02AC04

ATC

dextropropoxyphene; oral

3.4

16.4

178

ZXA00

NOMESCO Finland

Right side

1.7

16.4

355

2295

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.3

16.3

100

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.4

16.2

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

2.0

16.2

185

977

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

13.0

16.2

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

7.2

16.1

XA800

NOMESCO Finland

Neuropsychological investigation

3.0

16.1

248

205

Kela drug reimbursment

Chronic hypertension

1.8

16.0

310

1940

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.5

16.0

161

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

15.9

432

2963

D07AA02

ATC

hydrocortisone; topical

1.9

15.8

214

1198

L01BB01, ,

ATC

60.7

15.8

ZXA05

NOMESCO Finland

Left side

1.7

15.7

329

2103

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.6

15.7

360

B03BA03

ATC

hydroxocobalamin; parenteral

3.4

15.7

173

L93

ICD-10 Finland

Lupus erythematosus

+∞

15.6

F02.89*M32.8

ICD-10 Finland

Dementia in systemic lupus erythematosus

+∞

15.6

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

+∞

15.6

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

86.0

15.6

H53.1

ICD-10 Finland

Subjective visual disturbances

2.4

15.6

115

510

M05BA01

ATC

etidronic acid; systemic

13.9

15.5

69540

ICD-8 Finland

Erythematous condition, Lupus erythematosus

161.7

15.5

S76

ICPC

Skin infection other

2.7

15.5

339

R1250

NOMESCO Finland

Evaluation of functional capability

3.9

15.5

122

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

15.4

175

921

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

15.4

287

1773

R03AC02

ATC

salbutamol; inhalant

1.6

15.4

809

6467

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.4

15.4

112

493

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.8

15.4

282

R4190

NOMESCO Finland

Nutritional therapy

3.1

15.4

222

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

15.3

377

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

15.3

172

903

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

5.6

15.3

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

15.2

225

1296

H26.2

ICD-10 Finland

Complicated cataract

6.1

15.2

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

15.1

258

1553

A63.0

ICD-10 Finland

Anogenital (venereal) warts

3.0

15.1

235

D01AE16

ATC

amorolfine; topical

2.0

15.0

166

866

L50.9

ICD-10 Finland

Urticaria, unspecified

2.9

15.0

264

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.2

14.9

131

625

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.1

14.9

153

776

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.0

14.9

183

991

ZXE00

NOMESCO Finland

One hour or less

1.6

14.9

540

3960

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

32.1

14.8

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

4.5

14.8

A01AB04

ATC

amphotericin B; local oral

2.8

14.8

283

J01MA06

ATC

norfloxacin; oral

1.9

14.7

208

1180

H04AA01

ATC

glucagon; nasal, parenteral

25.3

14.7

D02AE01

ATC

carbamide; topical

2.4

14.7

101

434

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

+∞

14.6

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

+∞

14.6

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

+∞

14.6

R05

ICD-10 Finland

Cough

1.7

14.6

323

2093

UJF92

NOMESCO Finland

Capsular endoscopy

4.4

14.6

N05CF01

ATC

zopiclone; oral

1.6

14.5

437

3062

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

151.5

14.5

G73.7

ICD-10 Finland

Myopathy in other diseases classified elsewhere

151.5

14.5

E000002, ,

ATC

2.0

14.3

157

816

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.1

14.3

E10

ICD-10 Finland

Type 1 diabetes mellitus

27.5

14.3

ULA02

NOMESCO Finland

Kolposcopy

1.9

14.3

180

983

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

14.2

131

637

E000007, ,

ATC

2.5

14.2

378

L17

ICPC

Foot/toe symptom/complaint

1.6

14.2

446

3154

E000006, ,

ATC

2.3

14.2

107

479

S01KA02

ATC

hypromellose; ophthalmic

4.3

14.1

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

4.4

14.1

SPAT1229

SPAT

Assessment of need for aid

2.4

14.1

103

455

PAW37

NOMESCO Finland

Biopsy of temporal artery

14.6

14.1

R52.9

ICD-10 Finland

Pain, unspecified

2.0

14.1

155

807

JN4BD

NOMESCO Finland

Extensive body CT

2.1

14.0

142

716

H15.1

ICD-10 Finland

Episcleritis

4.9

14.0

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.9

14.0

234

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.8

14.0

112

N30.0

ICD-10 Finland

Acute cystitis

1.7

14.0

288

1826

A04

ICPC

Weakness/tiredness general

1.8

14.0

231

1376

XF404

NOMESCO Finland

Ambulatory ECG

2.2

13.9

120

568

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.4

13.9

432

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

12.8

13.9

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

5.1

13.9

M06

ICD-10 Finland

Other rheumatoid arthritis

53.9

13.8

A10AA01, ,

ATC

20.3

13.8

B01AB04

ATC

dalteparin; parenteral

2.6

13.8

323

ZX140

NOMESCO Finland

Intra articular

10.6

13.7

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

13.7

343

2289

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

13.7

395

2731

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

13.7

495

3609

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.6

13.7

312

UKC02

NOMESCO Finland

Cystoscopy

2.0

13.6

167

903

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.5

13.6

C07AB02

ATC

metoprolol; systemic

1.8

13.6

247

1512

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.9

13.6

101

7108X

ICD-9 Finland

Diffuse diseases of connective tissue, Other specified diffuse diseases of connective tissue

+∞

13.6

N08.5*M31.7

ICD-10 Finland

Glomerular disease states in microscopic polyangiitis

+∞

13.6

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

13.6

ZX100

NOMESCO Finland

Oral

5.5

13.6

M01AH01

ATC

celecoxib; oral

1.8

13.5

250

1538

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

141.3

13.5

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.1

13.4

180

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.9

13.4

218

XCK10

NOMESCO Finland

Photography of fundus of eye

2.3

13.4

107

491

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

13.4

732

5833

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.8

13.3

252

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.2

13.3

114

538

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

11.6

13.3

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

2.1

13.3

133

668

A01AB10

ATC

natamycin; local oral

3.1

13.2

177

D02BB01

ATC

betacarotene; oral

15.2

13.1

M19.2

ICD-10 Finland

Other secondary arthrosis

6.0

13.1

C01DA14

ATC

isosorbide mononitrate; oral

2.0

13.0

155

829

3AC01, ,

NOMESCO Finland

9.4

13.0

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

5.3

13.0

M01AB55

ATC

diclofenac, combinations; oral

2.4

12.9

414

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

12.9

199

1158

NDL52

NOMESCO Finland

Tenosynovectomy of hand

13.1

12.9

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

22.8

12.9

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

12.9

596

4572

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

2.7

12.9

257

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

50.5

12.9

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

50.5

12.9

K50.9

ICD-10 Finland

Crohn disease, unspecified

50.5

12.9

RJ421, ,

NOMESCO Finland

50.5

12.9

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

12.8

194

1124

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.1

12.8

132

671

R80

ICD-10 Finland

Isolated proteinuria

10.6

12.8

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

9.8

12.7

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

12.7

135

693

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.5

12.7

349

S01AA01

ATC

chloramphenicol; ophthalmic

2.5

12.6

319

R53

ICD-10 Finland

Malaise and fatigue

1.6

12.6

354

2426

R02

ICPC

Shortness of breath/dyspnoea

1.8

12.6

188

1084

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

12.6

525

3936

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

12.6

749

6045

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

+∞

12.5

K50.0

ICD-10 Finland

Crohn disease of small intestine

+∞

12.5

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

12.5

370

2567

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

24.5

12.5

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.0

12.5

183

C02KX01

ATC

bosentan; oral

131.1

12.5

K51.8

ICD-10 Finland

Other ulcerative colitis

131.1

12.5

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

131.1

12.5

M33.2

ICD-10 Finland

Polymyositis

131.1

12.5

XFE00

NOMESCO Finland

Epicardial ultrasonography

4.1

12.4

N03AF02

ATC

oxcarbazepine; oral

3.0

12.4

189

UJD02

NOMESCO Finland

Gastroscopy

2.7

12.4

268

K07.60

ICD-10 Finland

Snapping jaw

2.3

12.4

448

N03AX14

ATC

levetiracetam; systemic

3.3

12.4

142

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

12.4

378

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.8

12.3

217

XG410

NOMESCO Finland

Flow-volume spirometry

2.8

12.3

223

T78.4

ICD-10 Finland

Allergy, unspecified

2.5

12.3

323

NG1DA

NOMESCO Finland

X-ray of knees

4.2

12.3

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

10.6

12.3

M01AE02

ATC

naproxen; oral, rectal

1.5

12.3

806

6621

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

12.3

155

846

R04.0

ICD-10 Finland

Epistaxis

2.2

12.3

100

463

SBA00

NOMESCO Finland

Microbiological examinations

3.3

12.2

143

RT272, ,

NOMESCO Finland

37.9

12.2

K11.2

ICD-10 Finland

Sialoadenitis

2.8

12.2

213

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

4.5

12.2

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.8

12.1

100

RD210, ,

NOMESCO Finland

4.7

12.1

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

6.1

12.1

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

12.5

12.1

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.9

12.1

197

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

12.1

433

M79.6

ICD-10 Finland

Pain in limb

1.5

12.0

638

5012

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

8.8

12.0

EBA10

NOMESCO Finland

Operative extraction of tooth

1.8

12.0

176

1009

H57.1

ICD-10 Finland

Ocular pain

2.6

12.0

261

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

4.0

12.0

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.7

11.9

106

ZXD05

NOMESCO Finland

Urgent procedure

1.6

11.9

404

2887

N06AX21

ATC

duloxetine; oral

1.8

11.9

178

1026

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

2.1

11.9

121

612

M01AX01

ATC

nabumetone; oral

2.8

11.8

222

A02BA04

ATC

nizatidine; systemic

2.2

11.8

103

490

B81

ICPC

Anaemia vit B12/folate deficiency

3.7

11.8

102

SAA04

NOMESCO Finland

Special examination of mouth

2.4

11.8

342

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

11.7

186

1091

N06AB04

ATC

citalopram; systemic

1.6

11.7

288

1906

Z50.1

ICD-10 Finland

Other physical therapy

2.4

11.7

349

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.8

11.7

205

1238

J01EA01

ATC

trimethoprim; systemic

1.6

11.7

397

2835

R23.3

ICD-10 Finland

Spontaneous ecchymoses

3.5

11.7

117

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

4.5

11.7

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

11.6

193

1148

WW400

NOMESCO Finland

Plasmaferesis

65.5

11.6

A12AA12

ATC

[U] calcium acetate

65.5

11.6

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.5

11.6

431

3140

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

19.1

11.6

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

23.1

11.6

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

23.1

11.6

WX204

NOMESCO Finland

Axillary plexus blockaced

2.9

11.5

197

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.0

11.5

139

747

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.2

11.5

149

R60.0

ICD-10 Finland

Localized oedema

1.8

11.5

167

954

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

11.5

327

2243

K50.8

ICD-10 Finland

Other Crohn disease

+∞

11.5

K50.1

ICD-10 Finland

Crohn disease of large intestine

+∞

11.5

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

+∞

11.5

N08.5*M30.0

ICD-10 Finland

Glomerular disorders in polyarteritis nodosa

+∞

11.5

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.6

11.5

109

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

11.4

213

1309

129

Kela drug reimbursment

Idiopathic thrombocytopaenia or granulocytopenia

120.9

11.4

RT271, ,

NOMESCO Finland

120.9

11.4

R42

ICD-10 Finland

Dizziness and giddiness

1.6

11.4

317

2160

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.5

11.4

310

R81

ICPC

Pneumonia

2.7

11.4

221

A10AA02, ,

ATC

5.4

11.4

R4180

NOMESCO Finland

Podiatric therapy

8.4

11.3

M01CB03

ATC

auranofin; oral

35.3

11.3

RJ410, ,

NOMESCO Finland

35.3

11.3

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.9

11.3

194

M45

ICD-10 Finland

Ankylosing spondylitis

5.0

11.2

D05BB02

ATC

acitretin; oral

5.0

11.2

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

11.2

301

2034

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.2

11.2

447

R76.0

ICD-10 Finland

Raised antibody titre

17.2

11.2

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.1

11.2

146

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.0

11.2

162

TK820

NOMESCO Finland

Peritoneal dialysis

25.2

11.1

TK810

NOMESCO Finland

Hemofiltration

25.2

11.1

C07AG02

ATC

carvedilol; oral

2.4

11.1

320

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

11.1

1014

8813

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.7

11.1

236

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

11.0

208

1282

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

5.1

11.0

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

11.0

250

1620

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

4.9

11.0

SPAT1254

SPAT

Administration of medicine

1.8

10.9

182

1083

SPAT1325

SPAT

Vaccination

1.5

10.9

419

3067

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

3.5

10.9

108

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.9

10.9

L71.8

ICD-10 Finland

Other rosacea

3.7

10.8

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

10.8

167

971

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

10.8

371

2651

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

10.8

353

2495

A28

ICPC

Limited function/disability NOS

1.7

10.8

217

1362

D05AX52

ATC

calcipotriol, combinations; topical

3.0

10.7

155

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

10.7

203

1252

A07AA09

ATC

vancomycin; oral

4.8

10.7

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

10.7

379

2726

5BA08, ,

NOMESCO Finland

13.0

10.7

G35

ICD-10 Finland

Multiple sclerosis

60.5

10.6

L71.9

ICD-10 Finland

Rosacea, unspecified

2.9

10.6

178

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.9

10.6

178

S18

ICPC

Laceration/cut

1.5

10.6

618

4908

S01XA18

ATC

ciclosporin; ophthalmic

8.0

10.6

EB1WA, ,

NOMESCO Finland

11.3

10.6

D06BB04

ATC

podophyllotoxin; topical

2.3

10.5

334

L20

ICPC

Joint symptom/complaint NOS

2.6

10.5

248

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

10.5

309

2132

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.1

10.5

480

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.5

10.5

106

N30.9

ICD-10 Finland

Cystitis, unspecified

2.1

10.5

106

535

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

10.4

400

D51.0

ICD-10 Finland

Vitamin B12deficiency anaemia due to intrinsic factor deficiency

110.8

10.4

M35.2

ICD-10 Finland

Behçet disease

+∞

10.4

K75.4

ICD-10 Finland

Autoimmune hepatitis

+∞

10.4

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

+∞

10.4

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

+∞

10.4

M33.1

ICD-10 Finland

Other dermatomyositis

+∞

10.4

C09AA05

ATC

ramipril; oral

1.6

10.4

278

1875

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.6

10.4

D06BX01

ATC

metronidazole; topical

1.8

10.3

166

977

N03AX09

ATC

lamotrigine; oral

2.4

10.3

306

Z2445

NOMESCO Finland

Psychologist

2.6

10.3

227

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.9

10.3

NDG30

NOMESCO Finland

Fusion of wrist, total

18.9

10.3

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.0

10.3

115

602

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

23.5

10.2

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.8

10.2

176

X58

ICD-10 Finland

Exposure to other specified factors

1.7

10.2

201

1252

TQW40

NOMESCO Finland

Remowal of suture of skin

2.1

10.2

102

512

C09CA06

ATC

candesartan; oral

1.5

10.2

331

2331

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.5

10.2

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.3

10.2

365

V03AE02

ATC

sevelamer; oral

13.2

10.2

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.9

10.1

166

H26.02

ICD-10 Finland

Presenil cataract

3.2

10.1

129

D68.9

ICD-10 Finland

Coagulation defect, unspecified

11.4

10.1

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.7

10.0

195

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

10.0

255

1697

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

9.2

10.0

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.1

10.0

140

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.1

10.0

461

K29.4

ICD-10 Finland

Chronic atrophic gastritis

4.1

10.0

N06AX11

ATC

mirtazapine; oral

1.5

10.0

464

3520

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

9.9

138

2314

SPAT1255

SPAT

Intravenous administration of medicine

2.2

9.9

382

B01AC04

ATC

clopidogrel; oral

1.8

9.9

170

1019

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.2

9.9

389

N05BA04

ATC

oxazepam; oral

1.5

9.9

358

2579

C09CA01

ATC

losartan; oral

1.5

9.9

318

2233

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

16.8

9.9

TKC20

NOMESCO Finland

Catheterisation of bladder

2.3

9.9

357

K76.9

ICD-10 Finland

Liver disease, unspecified

4.3

9.9

TQW99

NOMESCO Finland

Other minor procedure on skin

2.4

9.9

287

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.3

9.8

332

AN1

Coronary angiography

2.0

9.8

108

562

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.5

9.8

245

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

9.8

313

2196

I20.00

ICD-10 Finland

Unstable angina

3.4

9.8

106

M35.7

ICD-10 Finland

Hypermobility syndrome

3.7

9.7

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

7.4

9.7

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

13.5

9.7

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

4.2

9.7

RJ511, ,

NOMESCO Finland

55.4

9.7

D06BB10

ATC

imiquimod; topical

2.2

9.6

367

PJA10

NOMESCO Finland

Exploration of lymph nodes

4.3

9.6

RS221, ,

NOMESCO Finland

4.3

9.6

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

9.6

495

3823

D06AX01

ATC

fusidic acid; topical

1.9

9.6

126

696

ZXA10

NOMESCO Finland

Bilateral

1.6

9.6

234

1542

B34.9

ICD-10 Finland

Viral infection, unspecified

2.8

9.5

166

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

4.1

9.5

D07XC01

ATC

betamethasone; topical

1.9

9.5

131

735

K99

ICPC

Cardiovascular disease other

3.2

9.5

118

ZZA00

NOMESCO Finland

Split skin graft

3.2

9.5

118

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

9.4

357

L04AA24

ATC

abatacept; parenteral

100.7

9.4

SCA02

NOMESCO Finland

Preventive oral health care

1.8

9.4

144

835

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

9.4

165

996

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

+∞

9.4

58199

ICD-8 Finland

Nephrotic syndrome

+∞

9.4

H3600, E103,

ICD-10 Finland

+∞

9.4

H3601, E103,

ICD-10 Finland

+∞

9.4

M31.7

ICD-10 Finland

Microscopic polyangiitis

+∞

9.4

L04AA17

ATC

[U] adalimumab

+∞

9.4

24409

ICD-8 Finland

Myxoedema, (hypothyreosis) NUD

+∞

9.4

H3603, E103,

ICD-10 Finland

+∞

9.4

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.9

9.4

151

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

5.2

9.4

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

2.5

9.4

238

RT274, ,

NOMESCO Finland

21.8

9.4

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

9.3

100

515

K02.1

ICD-10 Finland

Caries of dentine

1.4

9.3

814

6894

A03

ICPC

Fever

1.6

9.3

240

1600

R05

ICPC

Cough

1.5

9.3

355

2581

B37.08

ICD-10 Finland

Other candidal stomatitis

4.9

9.3

N05BA01

ATC

diazepam; systemic, rectal

1.7

9.3

172

1053

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

4.7

9.3

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

8.7

9.3

B03XA01

ATC

erythropoietin; parenteral

8.7

9.3

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic

10.7

9.3

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.0

9.3

141

M54.5

ICD-10 Finland

Low back pain

1.4

9.3

518

4054

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

3.5

9.2

H26.4

ICD-10 Finland

After-cataract

1.9

9.2

128

720

WW500

NOMESCO Finland

Blood transfusion

2.5

9.2

246

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

1.9

9.2

110

589

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.4

9.2

100

J94.8

ICD-10 Finland

Other specified pleural conditions

4.2

9.2

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.2

9.2

388

SPAT1153

SPAT

Removal of sutures

1.5

9.2

383

2836

SPAT1262

SPAT

Handing over of treatment supplies

1.7

9.2

175

1081

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

3.9

9.2

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

9.2

375

Z71.8

ICD-10 Finland

Other specified counselling

1.4

9.1

486

3768

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

5.1

9.1

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.0

9.1

132

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

9.1

113

614

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.5

9.0

218

WZC30

NOMESCO Finland

Teaching

1.6

9.0

204

1318

N87.1

ICD-10 Finland

Moderate cervical dysplasia

2.8

9.0

155

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

18.7

8.9

D69.0

ICD-10 Finland

Allergic purpura

24.2

8.9

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.8

8.9

WVA20

NOMESCO Finland

Medicine administration

2.9

8.9

150

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

8.9

333

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

12.6

8.9

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.5

8.9

214

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

4.7

8.8

C03AA03

ATC

hydrochlorothiazide; oral

1.9

8.8

108

583

WX320

NOMESCO Finland

Spinalanesthesy

1.5

8.8

323

2327

Z01.2

ICD-10 Finland

Dental examination

1.4

8.8

649

5320

N05CD07

ATC

temazepam; oral

1.8

8.8

138

806

A02BX02

ATC

sucralfate; oral

2.5

8.8

215

J01FA10

ATC

azithromycin; systemic

1.4

8.7

807

6868

L29

ICPC

Musculoskeletal sympt/complt other

1.8

8.7

127

725

SFA10

NOMESCO Finland

One-surface restoration

1.4

8.7

758

6385

RJ411, ,

NOMESCO Finland

14.1

8.7

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

14.1

8.7

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

50.3

8.7

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

50.3

8.7

M35

ICD-10 Finland

Other systemic involvement of connective tissue

50.3

8.7

G04BE03

ATC

sildenafil; oral

6.6

8.7

NHQ40

NOMESCO Finland

Amputation of toe

6.6

8.7

J01MA01

ATC

ofloxacin; systemic

1.9

8.7

104

558

C08CA13

ATC

lercanidipine; oral

1.7

8.7

185

1177

E000003, ,

ATC

2.4

8.7

266

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

7.7

8.7

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

8.6

103

553

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

16.4

8.6

A10AE04

ATC

insulin glargine; parenteral

2.1

8.5

406

N25.0

ICD-10 Finland

Renal osteodystrophy

27.7

8.5

K90.9

ICD-10 Finland

Intestinal malabsorption, unspecified

20.2

8.5

L53.9

ICD-10 Finland

Erythematous condition, unspecified

3.7

8.5

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

8.5

153

931

J01DA09

ATC

[U] cefadroxil

1.5

8.4

347

2556

L04AA11

ATC

[U] etanercept

90.6

8.4

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

90.6

8.4

120

Kela drug reimbursment

Hypogammaglobulinaemia

90.6

8.4

RJ210, ,

NOMESCO Finland

90.6

8.4

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

2.9

8.4

138

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

8.4

388

K65.0

ICD-10 Finland

Acute peritonitis

4.5

8.4

I50.1

ICD-10 Finland

Left ventricular failure

2.5

8.4

208

N05BB01

ATC

hydroxyzine; systemic

2.0

8.4

458

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

8.3

396

7100A, ,

ICD-10 Finland

+∞

8.3

286

Kela drug reimbursment

Ciclosporin eye drop

+∞

8.3

G70.0

ICD-10 Finland

Myasthenia gravis

+∞

8.3

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

+∞

8.3

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

+∞

8.3

4AA26, ,

NOMESCO Finland

+∞

8.3

2873A

ICD-9 Finland

Purpura and other haemorrhagic conditions, Primary thrombocytopenia[PURPURA THROMBOCYTOPENICA IDIOPATHICA (ITP)]

+∞

8.3

M31.0

ICD-10 Finland

Hypersensitivity angiitis

+∞

8.3

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

8.3

502

3965

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

10.8

8.3

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

8.3

106

581

K29

ICPC

Cardiovascular sympt/complt other

2.4

8.3

234

XF402

NOMESCO Finland

ECG with work load test

1.8

8.2

120

686

J01DA06

ATC

[U] cefuroxime

1.6

8.2

188

1217

G03.9

ICD-10 Finland

Meningitis, unspecified

14.6

8.2

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.7

8.2

173

1097

U02

ICPC

Urinary frequency/urgency

1.6

8.2

221

1488

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

7.6

8.2

S01BC03

ATC

diclofenac; ophthalmic

3.1

8.2

108

S01BA01

ATC

dexamethasone; ophthalmic

2.6

8.1

181

K92

ICPC

Atherosclerosis/periph vascular dis

4.8

8.1

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

8.1

120

689

L04AC07

ATC

tocilizumab; parenteral

33.5

8.1

L94.8

ICD-10 Finland

Other specified localized connective tissue disorders

33.5

8.1

R76.8

ICD-10 Finland

Other specified abnormal immunological findings in serum

33.5

8.1

XCH00

NOMESCO Finland

Eye pressure measurement

2.3

8.1

268

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

6.9

8.1

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

6.9

8.1

M79.1

ICD-10 Finland

Myalgia

1.6

8.1

224

1518

R63.4

ICD-10 Finland

Abnormal weight loss

2.4

8.1

243

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

8.1

411

3149

D69.9

ICD-10 Finland

Haemorrhagic condition, unspecified

9.0

8.0

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

22.2

8.0

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

22.2

8.0

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

22.2

8.0

S29

ICPC

Skin symptom/complaint other

1.5

8.0

282

2013

V03AE01

ATC

polystyrene sulfonate; oral

7.3

8.0

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

7.3

8.0

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.2

8.0

A02BA03

ATC

famotidine; systemic

2.5

8.0

189

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.3

7.9

A08

ICPC

Swelling

2.0

7.9

397

R03BA05

ATC

fluticasone; inhalant

1.5

7.9

241

1666

LEB00

NOMESCO Finland

Biopsy of vagina

2.9

7.9

121

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

7.8

252

1763

M04AA01

ATC

allopurinol; systemic

1.8

7.8

117

674

C02EA02, ,

ATC

2.6

7.8

173

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.2

7.8

305

-60

ICPC

Result test/procedure

2.1

7.8

352

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

7.8

129

766

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.7

7.8

149

921

R11

ICD-10 Finland

Nausea and vomiting

1.8

7.7

121

706

L94.9

ICD-10 Finland

Localized connective tissue disorder, unspecified

45.2

7.7

M07.3

ICD-10 Finland

Other psoriatic arthropathies

45.2

7.7

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

7.7

360

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.7

7.7

145

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.3

7.7

248

E86

ICD-10 Finland

Volume depletion

3.0

7.7

112

I25.2

ICD-10 Finland

Old myocardial infarction

2.3

7.7

242

R68.2

ICD-10 Finland

Dry mouth, unspecified

7.5

7.7

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

3.3

7.7

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

7.7

451

3537

SXC03

NOMESCO Finland

Other oral or dental procedure

4.5

7.7

M01AX17

ATC

nimesulide; oral

1.5

7.6

297

2159

N06AX16

ATC

venlafaxine; oral

1.6

7.6

195

1295

O99.7

ICD-10 Finland

Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium

18.5

7.6

GD2SN

NOMESCO Finland

Lung ventilation SPECT

8.1

7.6

N89.0

ICD-10 Finland

Mild vaginal dysplasia

8.1

7.6

LEB30

NOMESCO Finland

Destruction of lesion of vaginal mucosa

6.7

7.6

J01FA09

ATC

clarithromycin; systemic

1.4

7.6

414

3204

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

25.1

7.6

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

7.6

397

L14

ICPC

Leg/thigh symptom/complaint

1.8

7.5

117

682

U07

ICPC

Urine symptom/complaint other

1.8

7.5

113

652

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.1

7.5

103

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.4

7.5

201

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

7.5

406

SPAT1216

SPAT

Assessment of functional ability

1.6

7.4

179

1172

D05AX02

ATC

calcipotriol; topical

3.2

7.4

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.8

7.4

101

565

7148X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies

80.5

7.4

4430A

ICD-9 Finland

Other peripheral vascular disease, Raynaud's syndrome

80.5

7.4

9522

FHL

Synovectomy

80.5

7.4

NE1BA

NOMESCO Finland

Pelvis extensive X-ray examination

3.5

7.4

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

7.4

221

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.3

7.4

253

B01AB10

ATC

tinzaparin; parenteral

1.7

7.3

145

904

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

8.4

7.3

XQ802

NOMESCO Finland

Epicutan test

2.2

7.3

293

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.5

7.3

185

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

10.9

7.3

I68.2*M32.1

ICD-10 Finland

Cerebral arteritis in systemic lupus erythematosus

+∞

7.3

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

+∞

7.3

6954B

ICD-9 Finland

Erythematous conditions, Lupus erythematosus[LUPUS ERYTHEMATOSUS DISCOIDES DISSEMINATUS]

+∞

7.3

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

+∞

7.3

N08.5*M31.0

ICD-10 Finland

Glomerular disorders in Goodpasture's syndrome

+∞

7.3

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

+∞

7.3

M05.3

ICD-10 Finland

Rheumatoid arthritis with involvement of other organs and systems

+∞

7.3

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

+∞

7.3

SPAT1211

SPAT

Application of soft bandage

1.8

7.3

109

628

ZXC12

NOMESCO Finland

Pulse colorlaser

9.4

7.3

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

4.2

7.3

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

3.5

7.3

I20.09

ICD-10 Finland

Unstable angina

2.2

7.3

287

C01CA24

ATC

epinephrine; parenteral

1.9

7.2

540

-1, ,

NOMESCO Finland

1.4

7.2

431

3381

D07CC01

ATC

betamethasone and antibiotics; topical

1.6

7.2

155

987

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.8

7.2

122

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.4

7.2

205

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.8

7.2

105

601

R50.0

ICD-10 Finland

Fever with chills

30.2

7.2

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

30.2

7.2

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

30.2

7.2

J01XE01

ATC

nitrofurantoin; oral

3.0

7.1

106

L04AB05

ATC

certolizumab pegol; parenteral

20.1

7.1

SPAT1097

SPAT

Recording of ECG

1.6

7.1

163

1054

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

3.5

7.1

SPAT1104

SPAT

Monitoring of emergency patient

2.0

7.1

371

D64.8

ICD-10 Finland

Other specified anaemias

3.4

7.1

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

7.1

186

1243

L04AB06

ATC

golimumab; parenteral

12.1

7.1

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

6.1

7.1

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

8.8

7.1

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

7.0

110

642

R74

ICPC

Upper respiratory infection acute

1.4

7.0

471

3763

SPAT1252

SPAT

Overall medication plan or its review

2.0

7.0

366

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.1

7.0

298

S01

ICPC

Pain/tenderness of skin

2.1

7.0

325

R03BB04

ATC

tiotropium bromide; inhalant

1.8

7.0

112

658

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

7.0

176

1164

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

7.0

102

583

PD4AD

NOMESCO Finland

CT of lower extremity arteries

7.0

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

7.0

H16.0

ICD-10 Finland

Corneal ulcer

2.1

7.0

312

M81.8

ICD-10 Finland

Other osteoporosis

3.9

7.0

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.0

7.0

102

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

3.3

7.0

N03AG01

ATC

valproic acid; systemic, rectal

2.0

7.0

381

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.6

7.0

153

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

4.4

7.0

C07AA07

ATC

sotalol; systemic

2.6

7.0

159

C02AC05

ATC

moxonidine; oral

2.2

6.9

253

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

6.4

6.9

A03FA02

ATC

cisapride; oral, rectal

1.9

6.9

511

DFF00

NOMESCO Finland

Pure tone audiometry

1.7

6.9

131

807

H53.4

ICD-10 Finland

Visual field defects

2.9

6.9

108

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

5.5

6.9

N29

ICPC

Neurological sympt/complt other

3.1

6.9

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.0

6.9

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

6.9

148

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.1

6.9

307

N32.1

ICD-10 Finland

Vesicointestinal fistula

13.8

6.9

M79.3

ICD-10 Finland

Panniculitis, unspecified

13.8

6.9

R52.2

ICD-10 Finland

Other chronic pain

2.2

6.9

267

WX202

NOMESCO Finland

Supraclavicular plexus blockade

3.4

6.8

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.4

6.8

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.0

6.8

H35.7

ICD-10 Finland

Separation of retinal layers

4.1

6.8

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

6.8

117

702

S21

ICPC

Skin texture symptom/complaint

1.5

6.8

199

1362

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.2

6.8

275

U71

ICPC

Cystitis/urinary infection other

1.8

6.8

107

626

R06AX22

ATC

ebastine; oral

1.5

6.8

242

1726

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

6.8

204

C08DB01

ATC

diltiazem; oral

2.1

6.8

282

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

6.1

6.8

R2110

NOMESCO Finland

Giving the first information

1.8

6.8

552

NDG76

NOMESCO Finland

Fusion of DIP joint

5.7

6.8

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

40.2

6.8

K74.3

ICD-10 Finland

Primary biliary cirrhosis

40.2

6.8

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

40.2

6.8

K94

ICPC

Phlebitis/thrombophlebitis

3.1

6.8

C10AA05

ATC

atorvastatin; oral

1.4

6.8

474

3811

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.4

6.7

186

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

16.8

6.7

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

16.8

6.7

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

16.8

6.7

M48.0

ICD-10 Finland

Spinal stenosis

1.6

6.7

145

924

Angiography of the heart and coronary arteries

2.3

6.7

224

ZX114

NOMESCO Finland

Intramuscular

3.5

6.7

R06AE09

ATC

levocetirizine; oral

1.5

6.7

193

1316

M25.9

ICD-10 Finland

Joint disorder, unspecified

3.9

6.7

N07AA02

ATC

pyridostigmine; systemic

22.6

6.7

E06.3

ICD-10 Finland

Autoimmune thyroiditis

22.6

6.7

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.7

6.7

133

S70

ICPC

Herpes zoster

2.5

6.6

169

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.8

6.6

548

C08CA03

ATC

isradipine; systemic

4.0

6.6

183

Kela drug reimbursment

Lamotrigin and topiramate

5.9

6.6

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

2.9

6.6

100

L16

ICPC

Ankle symptom/complaint

1.6

6.6

169

1123

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

6.6

107

632

C01AA05

ATC

digoxin; systemic

2.0

6.6

382

D69.5

ICD-10 Finland

Secondary thrombocytopenia

12.3

6.6

RJ420, ,

NOMESCO Finland

12.3

6.6

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

6.6

180

1214

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.3

6.6

220

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.6

6.6

140

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

6.6

274

2015

R15

ICD-10 Finland

Faecal incontinence

2.3

6.6

201

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

8.7

6.6

N90.2

ICD-10 Finland

Severe vulvar dysplasia, not elsewhere classified

8.7

6.6

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

10.1

6.5

R07.1

ICD-10 Finland

Chest pain on breathing

3.0

6.5

H43.1

ICD-10 Finland

Vitreous haemorrhage

3.0

6.5

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

3.0

6.5

H53.2

ICD-10 Finland

Diplopia

2.4

6.5

177

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

6.5

104

612

N91.1

ICD-10 Finland

Secondary amenorrhoea

3.1

6.5

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.1

6.5

274

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

6.5

515

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

6.5

115

697

J01XC01

ATC

fusidic acid; systemic

3.5

6.4

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.0

6.4

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.0

6.4

378

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

6.4

295

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

70.2

6.4

3029

Kela drug reimbursment

Upadacitinib

70.2

6.4

0539X

ICD-9 Finland

Herpes zoster without mention of complication

70.2

6.4

RJ190, ,

NOMESCO Finland

70.2

6.4

M05.2

ICD-10 Finland

Rheumatoid vasculitis

70.2

6.4

N05.8

ICD-10 Finland

Unspecified nephritic syndrome, other

70.2

6.4

A41.8

ICD-10 Finland

Other specified sepsis

3.3

6.4

L18

ICPC

Muscle pain

2.1

6.4

302

B01AF01

ATC

rivaroxaban; oral

1.6

6.4

145

935

121

Kela drug reimbursment

Severe hypofunction of sexual glands

2.7

6.4

130

6489X

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Other current conditions classifiable elsewhere

7.4

6.4

L04AK01

ATC

leflunomide; oral

14.4

6.4

L01BB02

ATC

mercaptopurine; oral

14.4

6.4

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

6.4

140

896

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.6

6.4

142

R00.2

ICD-10 Finland

Palpitations

1.7

6.4

117

715

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.3

6.4

204

GD1UN

NOMESCO Finland

Lung circulation SPECT

8.2

6.3

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

8.2

6.3

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

2.4

6.3

173

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

5.2

6.3

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

5.2

6.3

SBB10

NOMESCO Finland

Dental impressions

1.8

6.3

497

R31

ICD-10 Finland

Unspecified haematuria

1.8

6.3

497

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

6.0

6.3

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

6.0

6.3

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.5

6.3

155

XJC00

NOMESCO Finland

Oesophageal manometry

11.1

6.3

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

11.1

6.3

NXL00

NOMESCO Finland

Biopsy of muscle

11.1

6.3

J01FA01

ATC

erythromycin; systemic

1.5

6.3

180

1226

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

3.0

6.3

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

6.3

264

J20

ICD-10 Finland

Acute bronchitis

1.6

6.3

140

900

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

18.1

6.3

N04.0

ICD-10 Finland

Nephrotic syndrome, minor glomerular abnormality

18.1

6.3

J99.1*M35.0

ICD-10 Finland

Respiratory disorders in sicca syndrome [Sjögren]

+∞

6.3

M30.8

ICD-10 Finland

Other conditions related to polyarteritis nodosa

+∞

6.3

253, ,

Kela drug reimbursment

+∞

6.3

N085, M328,

ICD-10 Finland

+∞

6.3

109

Kela drug reimbursment

Multiple sclerosis

+∞

6.3

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

+∞

6.3

4AB02, ,

NOMESCO Finland

+∞

6.3

3042, ,

Kela drug reimbursment

+∞

6.3

NDF68

NOMESCO Finland

Operation for osteochondritis of several joints of hand, open

+∞

6.3

A32.7

ICD-10 Finland

Listerial sepsis

+∞

6.3

RJ120, ,

NOMESCO Finland

+∞

6.3

O9989, M329,

ICD-10 Finland

+∞

6.3

N085, M318,

ICD-10 Finland

+∞

6.3

M31.2

ICD-10 Finland

Lethal midline granuloma

+∞

6.3

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

+∞

6.3

N085M, ,

ICD-10 Finland

+∞

6.3

SPAT1301

SPAT

No procedures

1.4

6.3

368

2871

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.0

6.2

326

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

6.2

536

ZXX09

NOMESCO Finland

Extent of procedure, more than 8 units

26.8

6.2

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

26.8

6.2

RJ425, ,

NOMESCO Finland

26.8

6.2

NDG77

NOMESCO Finland

Other excision, reconstruction or fusion of joint of first finger

26.8

6.2

N05.9

ICD-10 Finland

Unspecified nephritic syndrome, unspecified

26.8

6.2

1CX01, ,

NOMESCO Finland

26.8

6.2

L56.4

ICD-10 Finland

Polymorphous light eruption

7.1

6.2

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.1

6.2

H25.8

ICD-10 Finland

Other senile cataract

1.7

6.2

115

705

S01AD03

ATC

aciclovir; ophthalmic

2.2

6.2

226

H16.9

ICD-10 Finland

Keratitis, unspecified

3.2

6.2

A07EA02

ATC

hydrocortisone; rectal

6.3

6.2

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.4

6.2

M05BX03

ATC

strontium ranelate; oral

5.8

6.1

R4140

NOMESCO Finland

Psychotherapy

5.8

6.1

E000004, ,

ATC

2.8

6.1

110

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

6.1

918

8200

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

7.7

6.1

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

7.7

6.1

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

7.7

6.1

H25.0

ICD-10 Finland

Senile incipient cataract

1.8

6.1

451

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

12.6

6.1

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.4

6.1

164

L50.0

ICD-10 Finland

Allergic urticaria

2.3

6.1

189

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

8.6

6.1

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

3.1

6.1

N87.0

ICD-10 Finland

Mild cervical dysplasia

2.3

6.1

183

XQ800

NOMESCO Finland

Prick test

1.7

6.1

103

617

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.1

6.0

248

PD5BD

NOMESCO Finland

Extensive CT of aorta

3.6

6.0

J05AH02

ATC

oseltamivir; oral

6.7

6.0

196

Kela drug reimbursment

Paricalcitol and cinacalcet

10.1

6.0

NDG74

NOMESCO Finland

Fusion of first IP joint

10.1

6.0

J04BA02

ATC

dapsone; oral

10.1

6.0

A29

ICPC

General symptom/complaint other

1.5

6.0

164

1105

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

266

171

18.85

316.84

1.7

1.2

5.75

4.64

u/ml

0.28

170

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

214

30.10

315.26

1.8

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

203

34.08

312.28

1.8

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

198

35.15

307.80

1.8

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

511

278

27.92

307.65

2.1

1.2

18.48

2.27

u/ml

3.49

171

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

515

301

26.06

307.65

2.1

1.2

39.47

3.20

u/ml

4.66

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

506

278

27.50

307.65

2.1

1.2

13.45

8.58

u/ml

0.37

201

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

449

208

30.90

307.65

2.0

1.1

2.11

1.51

u/ml

0.46

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

877

247

89.07

307.65

7.6

1.2

0.18

0.25

g/l

22.84

846

235

(3015171) Extractable nuclear Ab [Units/volume] in Serum

466

391

17.13

307.65

2.0

1.2

3.05

1.10

u/ml

0.97

(3005719) IgG [Mass/volume] in Serum or Plasma

476

699

9.67

307.65

4.4

2.6

11.19

10.56

g/l

1.48

460

630

(3037522) Nuclear Ab [Titer] in Serum

836

1503

11.86

307.65

2.8

1.3

1022.06

364.88

titre

22.34

524

254

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

876

258

84.96

307.65

7.6

1.3

1.04

1.24

g/l

15.29

852

244

(3023420) DNA double strand Ab [Units/volume] in Serum

891

369

61.58

307.65

9.0

1.3

25.14

6.53

iu/ml

7.04

493

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

390

238

22.09

307.65

2.0

1.1

59.33

23.01

u/ml

2.81

107

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

193

61.74

307.65

1.5

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

199

33.79

305.50

1.8

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

199

33.79

305.50

1.8

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

203

31.76

305.21

1.8

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

195

34.53

301.61

1.8

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

196

33.20

299.35

1.8

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

252

175

17.24

287.70

1.7

1.2

9.42

3.60

u/ml

1.82

154

(42870588) Differential panel, method unspecified - Blood

992

3648

6.51

261.40

15.9

4.5

—

(4268621) Lupus anticoagulant assay

204

129

18.26

243.47

3.0

2.2

—

(3001604) Monocytes [#/volume] in Blood

1226

5883

8.24

226.32

18.2

4.3

0.56

e9/l

0.02

1160

4963

(3006315) Basophils [#/volume] in Blood

1227

5904

8.23

225.42

18.3

4.3

0.04

e9/l

4.31

1160

4976

(3019069) Monocytes/Leukocytes in Blood

1171

5416

7.18

224.55

18.5

4.5

9.27

8.54

11.91

1137

5051

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

206

155

15.34

223.69

1.6

1.4

0.10

0.12

iu/ml

0.10

(3006504) Eosinophils/Leukocytes in Blood

1166

5408

7.04

221.71

18.4

4.4

2.47

2.75

3.95

1132

5032

(3018010) Neutrophils/Leukocytes in Blood

1173

5473

7.13

221.38

17.8

4.3

58.72

56.78

6.25

1143

5205

(3022096) Basophils/Leukocytes in Blood

1165

5418

6.99

220.21

18.6

4.4

0.68

0.07

1135

5029

(3013115) Eosinophils [#/volume] in Blood

1235

6133

8.06

213.94

18.7

4.5

0.15

0.18

e9/l

14.96

1174

5266

(3019198) Lymphocytes [#/volume] in Blood

1225

6060

7.79

212.43

18.4

4.3

1.65

1.93

e9/l

13.24

1174

5272

(3028026) IgM [Mass/volume] in Serum or Plasma

345

563

7.74

212.22

2.1

1.8

1.29

1.48

g/l

0.77

321

506

(3002030) Lymphocytes/Leukocytes in Blood

1172

5590

6.86

211.55

18.3

4.4

26.63

28.47

7.13

1146

5286

(3004616) Nuclear Ab [Presence] in Serum

180

128

15.93

201.26

2.0

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

244

316

9.09

181.96

1.4

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1257

6839

7.53

181.14

21.1

7.9

3.79

4.02

e9/l

3.26

1193

5842

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

426

1146

4.86

149.68

3.9

4.5

242.39

254.04

u/l

0.54

415

1088

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

235

382

7.15

142.54

2.4

1.5

1.50

1.51

g/l

0.08

211

331

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1037

5587

4.05

129.96

3.9

2.3

81.51

77.50

nmol/l

4.92

998

5078

(3017732) Neutrophils [#/volume] in Blood

435

1344

4.20

125.25

3.6

2.8

3.83

5.09

e9/l

1.81

371

1174

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

463

1500

4.07

124.72

3.7

2.3

21.78

22.68

0.73

443

1403

(3020630) Protein [Mass/volume] in Serum or Plasma

326

809

4.91

124.71

2.1

3.1

66.04

67.04

g/l

1.34

307

743

(3002179) Metamyelocytes/Leukocytes in Blood

340

874

4.78

124.53

7.2

3.4

0.46

0.76

1.97

151

229

(3004789) Transferrin [Mass/volume] in Serum or Plasma

489

1658

3.95

123.25

3.7

2.2

2.20

2.38

g/l

10.29

469

1538

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

774

3562

3.53

121.46

3.4

2.0

191.58

202.64

u/l

0.09

751

3383

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

147

167

9.69

120.24

6.0

6.3

259.25

353.71

iu/ml

0.19

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1050

5904

3.86

118.64

11.5

6.2

1.22

mmol/l

0.61

953

5138

(3021601) Nitrite [Presence] in Urine by Test strip

1107

6460

4.07

117.81

8.0

3.5

0.00

estimate

0.80

256

1234

(3022948) Iron [Moles/volume] in Serum or Plasma

504

1792

3.79

117.73

3.8

2.2

11.69

13.53

umol/l

7.59

485

1672

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

19.05

116.52

1.3

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

1111

6528

4.06

116.31

8.0

3.5

20.10

3.88

estimate

0.94

263

1267

(3027945) Reticulocytes/Erythrocytes in Blood

375

1093

4.29

116.06

3.9

2.3

1.81

1.76

0.38

349

984

(3015736) pH of Urine

961

5168

3.58

115.11

6.3

3.1

6.32

6.23

1.64

502

2933

(3017181) Myelocytes/Leukocytes in Blood

340

929

4.48

114.52

8.0

3.5

0.66

0.98

1.88

145

245

(3009261) Glucose [Presence] in Urine by Test strip

1113

6588

4.02

114.24

8.1

3.5

0.02

0.26

estimate

0.49

253

1214

(3024561) Albumin [Mass/volume] in Serum or Plasma

953

5165

3.49

111.26

8.0

4.3

34.80

36.13

g/l

10.78

909

4856

(3000850) Epithelial cells [#/volume] in Urine

604

2500

3.44

110.11

5.5

2.4

4.60

7.61

e6/l

6.49

571

2242

(3023520) Reticulocytes [#/volume] in Blood

310

815

4.57

109.40

3.3

2.3

69.67

71.66

e9/l

0.36

210

596

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

15.00

107.45

1.4

1.1

1.12

1.05

ratio

1.81

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

951

5258

3.37

105.07

9.6

5.6

1.22

mmol/l

0.53

913

4860

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

128

148

9.39

103.04

2.7

3.4

100.00

348.57

u/ml

—

(3021440) Promyelocytes/Leukocytes in Blood

320

900

4.28

102.95

8.2

3.5

0.01

0.13

4.60

125

217

(3025159) Blasts/Leukocytes in Blood

319

902

4.26

101.81

8.5

3.7

0.35

0.49

0.10

122

192

(3018095) Leukocytes [#/volume] in Urine

843

4448

3.16

98.80

9.5

3.4

74.11

74.98

e6/l

0.02

659

2971

(3045424) Erythrocytes [Presence] in Urine

226

504

5.13

96.97

3.3

2.0

0.00

0.02

estimate

0.50

158

(3007164) IgA [Mass/volume] in Serum or Plasma

579

2486

3.22

96.97

1.9

1.4

2.38

2.24

g/l

1.19

404

1502

(3002582) Erythrocytes [#/volume] in Urine

754

3773

3.09

96.39

7.3

2.8

92.85

62.00

e6/l

0.17

640

2762

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1302

9063

5.50

95.81

15.0

3.3

15.65

11.34

mm/h

22.19

1273

8484

(3011412) CD3 cells [#/volume] in Blood

13.92

93.66

2.6

3.3

882.77

1236.66

e6/l

1.39

(3023368) Bacteria identified in Blood by Culture

632

2918

3.08

92.32

6.4

3.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

662

3143

3.05

91.89

3.9

2.9

1322.77

1082.40

ng/l

0.78

587

2636

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

16.21

89.40

1.2

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

141

218

7.06

88.52

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

664

3215

2.97

88.05

7.2

2.8

0.26

0.48

e6/l

2.09

550

2236

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

186

380

5.47

87.90

1.7

2.4

3.09

2.91

g/l

1.31

175

347

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1302

9291

5.13

86.96

18.4

6.8

74.17

77.69

u/l

2.17

1282

8772

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

191

404

5.30

86.77

1.7

2.4

7.21

7.35

g/l

0.49

180

371

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

191

404

5.30

86.77

1.7

2.4

3.50

3.66

g/l

0.81

180

371

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

191

404

5.30

86.77

1.7

2.4

4.12

4.26

g/l

1.35

180

371

(3018418) pH of Serum or Plasma

696

3478

2.94

86.73

6.7

3.7

7.40

0.68

548

2404

(3020779) Urea [Moles/volume] in Serum or Plasma

296

895

3.90

85.00

10.7

6.7

9.75

8.86

mmol/l

1.30

289

858

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

175

349

5.57

84.85

1.8

2.5

0.32

1.34

g/l

2.78

159

307

(3003458) Phosphate [Moles/volume] in Serum or Plasma

386

1394

3.42

84.58

9.7

4.9

1.08

1.04

mmol/l

1.80

364

1286

(40768443) Skin Pathology biopsy report

209

488

4.84

84.45

1.3

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

173

343

5.60

84.41

1.8

2.4

11.54

10.17

g/l

2.73

160

308

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

160

296

5.96

84.06

1.8

2.3

0.00

0.01

g/l

0.80

148

274

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

616

2931

2.92

83.32

3.2

2.1

2.88

2.76

mg/l

0.53

560

2517

(3033099) Centromere Ab [Titer] in Serum

34.35

83.12

1.3

1.1

—

(40768446) Kidney Pathology biopsy report

24.56

82.74

1.3

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

112

148

8.12

80.70

1.4

1.1

673.33

94.00

titre

—

(3034426) Prothrombin time (PT)

21.93

79.10

1.4

1.2

29.98

26.57

2.03

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

146

264

6.04

78.43

1.8

2.4

0.00

g/l

-0.00

139

256

(40760892) CBC W Ordered Manual Differential panel - Blood

563

2620

2.88

78.42

11.0

3.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

151

285

5.80

77.53

1.8

2.4

0.00

g/l

-0.00

139

257

(3045414) Leukocytes [Presence] in Urine

321

1095

3.48

76.30

3.1

2.0

0.00

estimate

-0.00

207

(3017143) Hepatitis C virus Ab [Presence] in Serum

347

1245

3.35

76.06

1.7

1.6

—

(3026782) Osmolality of Urine

487

2128

2.95

75.83

6.2

2.7

498.08

521.56

mosm/kgh2o

1.81

450

1846

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

493

2176

2.92

75.26

1.4

1.2

14.93

2.76

u/ml

3.34

208

824

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

15.42

73.70

2.7

3.8

120.90

229.24

e6/l

2.22

(3036481) Cortisol [Moles/volume] in Serum or Plasma

311

1072

3.42

72.41

2.1

349.06

386.68

nmol/l

2.54

286

996

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

15.17

71.94

2.6

3.5

407.58

682.06

e6/l

0.65

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

12.89

70.52

2.0

1.1

5.72

5.61

u/l

0.03

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

181

434

4.63

70.34

1.7

2.2

40.07

40.24

u/l

0.03

165

391

(3021589) Normoblasts [#/volume] in Blood

873

5289

2.65

69.36

23.0

9.0

0.00

e9/l

0.95

780

4201

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

512

2398

2.76

68.78

1.4

1.3

40.74

21.54

iu/ml

2.51

177

663

(3024980) IgG subclass 4 [Mass/volume] in Serum

103

156

7.03

65.63

1.6

1.7

0.50

0.86

g/l

2.02

124

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

265

889

3.43

63.87

5.8

3.3

91.71

77.00

ng/l

2.06

243

783

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

12.13

63.07

2.3

3.0

—

(3014051) Protein [Presence] in Urine by Test strip

664

3652

2.52

62.81

5.6

2.7

0.17

0.03

0.35

(3011397) Hemoglobin [Presence] in Urine by Test strip

579

3012

2.54

61.40

7.0

3.3

0.00

0.16

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

105

175

6.39

61.00

1.3

336.64

244.91

u/ml

1.03

105

(3007566) Smooth muscle Ab [Titer] in Serum

132

273

5.22

61.00

1.3

1.2

223.64

83.33

titre

0.63

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

966

6364

2.57

60.95

7.6

6.3

10.12

10.96

umol/l

1.46

929

6054

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

111

199

5.96

59.89

1.3

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

243

808

3.41

59.13

1.4

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

140

317

4.78

58.11

1.9

3.9

48.31

74.05

mg/l

0.60

117

280

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

140

318

4.77

57.88

1.9

3.8

39.25

58.92

mg/l

0.86

117

280

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

126

270

5.02

55.81

1.7

2.4

12.26

11.55

mg/l

0.44

117

253

(3042936) Bacteria identified in Isolate by Culture

364

1576

2.75

55.34

2.6

1.8

—

(3035715) Granulocytes [#/volume] in Blood

133

6.90

54.85

5.2

2.5

3.64

4.43

e9/l

2.43

133

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

403

1844

2.65

54.83

2.6

1.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

430

2044

2.57

53.96

5.7

2.5

0.96

1.11

e6/l

0.37

280

999

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

100

181

5.86

53.35

1.3

1.4

159.55

149.41

au/ml

0.34

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

143

355

4.36

52.78

2.3

1.9

159.31

862.82

ug/l

0.69

135

337

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

11.90

52.71

2.2

2.4

41.50

40.42

0.09

(3032080) INR in Blood by Coagulation assay

808

5123

2.31

52.23

22.4

12.5

1.29

1.20

inr

4.59

707

4179

(3009508) Creatinine [Moles/volume] in Urine

655

3816

2.31

51.63

6.8

3.0

6.83

7.39

mmol/l

2.54

592

3235

(3029937) Albumin [Presence] in Urine by Test strip

613

3474

2.33

51.56

8.3

3.6

0.00

0.01

estimate

1.74

246

1165

(3018677) aPTT in Platelet poor plasma by Coagulation assay

366

1648

2.64

51.00

3.0

2.1

30.32

29.10

2.34

358

1606

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

409

1944

2.54

50.93

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

622

3567

2.31

50.65

8.1

3.6

18.24

7.50

mg/mmol

3.09

437

2080

(3037756) Immunofixation for Serum or Plasma

102

198

5.47

50.46

1.2

1.7

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

14.95

50.37

1.3

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

108

222

5.18

50.11

1.9

1.5

15869.11

9966.11

e6/l

0.36

155

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

123

283

4.66

49.93

1.8

3.4

3.02

4.56

ratio

0.31

161

(3021447) Carbon dioxide [Partial pressure] in Venous blood

269

1043

2.94

49.89

4.9

3.4

5.80

5.82

kpa

0.05

258

1017

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

128

307

4.48

49.32

4.5

4.6

1.69

1.37

mg/l

3.47

121

282

(3012516) Albumin [Mass/volume] in Urine

611

3515

2.28

48.97

6.9

3.0

99.77

43.66

mg/l

3.56

425

2081

(3012095) Magnesium [Moles/volume] in Serum or Plasma

393

1869

2.52

48.58

4.0

3.4

0.82

mmol/l

0.30

375

1776

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

206

702

3.26

47.67

2.1

1.6

—

(3035933) Granulocytes/Leukocytes in Blood

195

5.32

47.14

5.0

2.5

59.80

59.42

0.09

195

(37208534) Antinuclear antibody arbitrary concentration in serum

13.24

47.01

1.8

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

107

231

4.92

46.87

1.6

1.3

—

(3012544) pH of Venous blood

265

1052

2.86

46.86

5.0

3.4

7.37

7.39

2.02

159

565

(3001122) Ferritin [Mass/volume] in Serum or Plasma

902

6150

2.25

46.75

4.6

2.9

159.07

97.40

ug/l

8.11

863

5790

(3002032) Base excess in Venous blood by calculation

257

1011

2.88

46.18

5.0

3.5

1.55

1.90

mmol/l

0.71

222

892

(3000494) Fungus identified in Specimen by Culture

326

1449

2.61

46.16

1.7

1.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1104

8237

2.45

45.51

7.4

4.4

1347.18

3063.98

e6/l

0.65

102

(3037121) Protein [Mass/volume] in Urine

134

357

4.04

44.86

5.2

3.5

347.75

316.50

mg/l

0.15

147

(40758558) Short blood count panel - Blood

624

3719

2.19

44.82

12.0

5.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

116

6.48

43.11

2.5

2.4

1.15

0.89

g/24h

0.44

(3048689) Calprotectin [Mass/mass] in Stool

322

1467

2.54

43.02

2.8

1.3

114.47

91.61

ug/g

0.77

269

1115

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

133

364

3.92

42.85

2.1

1.9

1.32

1.91

ug/l

0.37

126

324

(3019309) Folate [Moles/volume] in Red Blood Cells

351

1670

2.46

42.68

1.9

1.6

1125.32

1152.13

nmol/l

0.23

287

1251

(3026493) Urate [Moles/volume] in Serum or Plasma

514

2879

2.22

42.66

3.9

2.5

333.78

323.33

umol/l

1.30

468

2553

(3030981) Hyaline casts [#/volume] in Urine by Automated count

229

891

2.87

41.74

4.5

2.1

0.19

0.51

e6/l

2.17

222

847

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

302

1354

2.56

41.60

2.3

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

522

2968

2.19

41.49

1.5

1.3

1.29

u/ml

0.00

126

786

(3026008) Bacteria identified in Urine by Culture

638

3937

2.11

40.86

4.0

3.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

378

1898

2.34

40.45

6.3

2.5

2.42

3.57

e6/l

1.70

228

859

(3010375) cycloSPORINE [Mass/volume] in Blood

14.04

40.03

33.4

37.0

98.00

134.55

ug/l

1.58

(3048929) Epstein Barr virus Ab [Presence] in Serum

127

353

3.85

39.99

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

10.52

39.69

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

10.52

39.69

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

433

2331

2.23

39.03

1.9

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

8.71

38.38

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

120

330

3.88

38.33

2.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

294

1351

2.48

38.15

2.2

1.6

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

12.17

37.76

1.2

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

12.17

37.76

1.2

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

12.17

37.76

1.2

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

12.17

37.76

1.2

1.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

107

274

4.14

37.70

1.6

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

180

649

3.03

37.48

5.8

3.5

5.10

5.17

kpa

0.58

175

626

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

497

2867

2.12

37.25

2.5

1.8

1.46

1.05

mg/l

2.51

410

2214

(4062490) Immunoglobulin typing, IgG

101

6.37

36.70

1.5

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

547

3296

2.06

36.27

2.0

1.6

19.08

20.62

nmol/l

1.89

480

2768

(3027135) IgG subclass 1 [Mass/volume] in Serum

6.39

36.24

1.5

1.4

7.32

6.68

g/l

0.54

(3028192) IgG subclass 2 [Mass/volume] in Serum

6.39

36.24

1.5

1.4

2.74

2.99

g/l

0.40

(3024139) IgG subclass 3 [Mass/volume] in Serum

6.39

36.24

1.5

1.4

0.52

0.37

g/l

0.95

(3009343) pH of Capillary blood

175

635

3.00

35.98

5.6

3.5

7.42

0.21

149

537

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

772

5270

2.00

35.89

2.4

2.0

101.21

97.94

pmol/l

1.13

436

2666

(3019225) pH of Specimen

249

1090

2.55

35.64

7.1

4.0

7.37

7.35

1.08

211

756

(3000093) Morphology [Interpretation] in Blood Narrative

7.20

35.34

1.2

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

671

4384

1.99

35.15

4.1

3.5

2.33

2.36

mmol/l

6.95

620

4007

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

111

307

3.83

35.13

1.4

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

101

263

4.05

34.77

4.3

3.9

0.33

0.42

iu/ml

1.75

146

(3008757) Leukocyte morphology finding [Identifier] in Blood

6.48

34.40

3.5

4.2

—

(21494814) CD8 cells/Lymphocytes in Specimen

11.93

34.37

2.3

2.6

32.77

30.63

0.26

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

277

1294

2.41

34.37

2.4

1.7

—

(3022313) Gas panel - Capillary blood

141

464

3.26

34.20

6.0

3.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

566

3525

2.00

33.62

6.9

3.0

0.00

0.31

estimate

0.64

221

969

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

202

820

2.70

33.59

2.7

2.4

31.53

21.48

au/ml

0.49

100

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

7.49

33.20

1.1

294.00

254.21

mg/l

0.41

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

189

749

2.75

32.91

1.4

1.3

60.27

41.54

au/ml

0.57

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

723

4931

1.94

32.57

7.7

3.4

0.00

0.14

estimate

0.82

221

998

(3013826) Glucose [Moles/volume] in Serum or Plasma

932

6925

1.98

32.45

6.2

4.2

6.27

6.45

mmol/l

2.08

898

6486

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

6.44

31.84

1.4

1.2

—

titre

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

116

356

3.46

31.41

4.3

2.7

194.73

179.09

1.01

109

338

(3033658) Prothrombin time (PT) actual/Normal

506

3094

1.98

31.16

5.9

3.7

91.61

93.48

0.88

493

3036

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

6.86

30.71

1.3

1.1

55.60

41.67

mg/l

0.61

(40768797) Stomach Pathology biopsy report

321

1679

2.17

30.08

1.3

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

647

4332

1.90

30.07

4.6

3.3

158.33

37.62

ng/l

0.56

476

2765

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

151

560

2.89

29.68

5.5

3.4

1.54

1.88

mmol/l

0.38

119

422

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

625

4155

1.89

29.55

4.2

3.0

33.54

30.63

u/l

0.78

595

3937

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

6.71

29.48

1.7

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

186

772

2.62

29.43

4.3

2.9

208.85

174.02

ng/l

0.43

174

699

(3024354) Oxygen [Partial pressure] in Venous blood

204

890

2.51

29.08

4.1

3.1

4.60

4.45

kpa

0.55

193

868

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

280

3.64

28.80

1.5

1.3

—

(36660697) Celiac disease serology panel - Serum

226

1044

2.38

28.39

1.3

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

231

1079

2.36

28.29

2.6

2.1

0.19

0.22

g/l

4.39

216

1032

(3036489) Thrombin time

130

456

3.03

28.20

3.7

2.2

21.56

20.72

0.64

117

403

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

296

3.52

27.87

1.6

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

180

4.28

27.86

1.5

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

202

4.08

27.84

1.5

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

244

3.78

27.70

1.5

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

200

4.07

27.38

1.4

1.3

—

(3000991) Gas panel - Venous blood

209

951

2.40

27.09

9.0

7.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

220

3.89

27.05

1.2

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

573

3797

1.84

26.62

3.0

2.3

58.07

60.87

u/l

0.58

537

3521

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

121

4.95

26.37

1.4

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

115

393

3.09

26.07

2.6

1.8

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

5.54

25.36

1.8

1.3

55.11

65.51

0.92

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

119

430

2.93

24.44

2.7

1.9

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

129

4.64

24.44

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

7.01

24.25

1.3

1.1

0.54

ratio

0.02

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

375

2227

1.92

24.10

5.4

3.4

462.67

283.13

ng/l

0.48

300

1564

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

120

4.73

23.72

1.5

1.6

—

(4195642) Thrombophilia screening test

176

4.01

23.57

1.4

1.1

—

(3044941) Cell count panel - Synovial fluid

177

3.98

23.39

1.7

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

319

3.15

22.80

1.4

1.3

—

(3028433) Virus identified in Specimen by Culture

9.47

22.68

1.4

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

6.20

21.63

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

117

4.57

21.61

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

156

4.04

21.50

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

293

3.17

21.47

3.8

3.4

2.26

2.18

index

0.02

159

(3019174) dRVVT (LA screen)

26.86

21.38

1.4

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

326

3.05

21.36

3.5

2.5

24.62

24.93

mmol/l

0.32

321

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

149

646

2.46

21.30

2.0

1.7

—

(3044009) aPTT.lupus sensitive (LA screen)

28.52

20.98

1.6

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

113

4.55

20.67

1.1

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

586

4135

1.70

20.44

2.9

2.2

—

(44806071) Cardiolipin IgM antibody measurement

20.39

20.41

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

467

3110

1.74

20.01

2.8

2.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

4.71

19.46

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

111

4.44

19.29

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

339

2.86

18.77

1.4

341.46

319.06

ug/g

0.46

195

(3010144) Erythrocytes [#/volume] in Synovial fluid

4.93

18.32

1.6

1.2

203118.00

236228.46

e6/l

0.05

(3044290) Cell count panel - Cerebral spinal fluid

230

3.24

18.26

1.3

1.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

247

1392

1.93

18.05

2.8

2.9

6.78

7.48

umol/l

0.31

218

1216

(3005322) IgE [Units/volume] in Serum or Plasma

179

900

2.13

17.94

1.2

1.3

125.70

181.35

u/ml

0.86

162

829

(3042111) Morphology [Interpretation] in Bone marrow Narrative

173

3.58

17.85

1.4

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

18.32

17.81

1.3

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

188

3.46

17.80

1.3

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1354

12340

2.59

17.60

37.6

12.6

19.29

23.33

mg/l

6.55

1257

9871

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

162

3.62

17.33

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

217

3.24

17.28

1.7

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

213

3.25

17.13

1.4

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

266

3.00

17.12

1.6

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

144

677

2.25

17.04

2.8

3.3

4.23

4.56

pmol/l

3.94

129

612

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

105

429

2.56

16.98

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

382

2500

1.72

16.95

3.1

2.8

2.46

2.45

mmol/l

0.58

349

2256

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

138

3.79

16.65

1.4

1.1

80.38

98.55

3.48

127

(3044927) Protein electrophoresis panel - Urine

4.63

16.63

1.2

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

5.64

16.53

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

5.64

16.53

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

5.64

16.53

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

5.64

16.53

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

364

2.66

16.40

1.2

1.1

6.18

4.92

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

178

3.41

16.40

1.3

1.1

111.61

117.09

0.49

161

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

169

861

2.09

16.32

5.4

3.5

1.23

mmol/l

1.04

160

735

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

14.68

15.86

1.4

1.3

9.00

8.68

ug/l

0.09

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

214

3.13

15.70

1.5

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

214

3.13

15.70

1.5

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

164

843

2.07

15.44

2.6

2.2

6.76

6.31

ug/l

0.15

142

741

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

5.81

15.43

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1142

9931

1.72

15.31

5.4

3.3

14.82

14.42

pmol/l

6.61

1073

9167

(3027273) Bicarbonate [Moles/volume] in Venous blood

106

457

2.42

15.29

3.5

2.6

24.86

25.63

mmol/l

1.49

101

441

(3017704) Immunofixation for Urine

6.34

15.04

1.0

2.1

—

(44790049) Parainfluenza type 3 nucleic acid detection

153

3.49

15.03

1.7

1.2

—

(44790047) Parainfluenza type 1 nucleic acid detection

153

3.49

15.03

1.7

1.2

—

(44790048) Parainfluenza type 2 nucleic acid detection

153

3.49

15.03

1.7

1.2

—

(44806118) Parainfluenza type 4 nucleic acid detection

153

3.49

15.03

1.7

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

107

4.01

14.92

1.5

1.3

4112.03

2176.10

e6/l

0.79

(3012441) Differential panel - Pleural fluid

4.39

14.81

1.4

1.3

—

(3022145) Colonoscopy Study observation

218

1256

1.87

14.71

1.4

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

5.17

14.61

1.1

1.0

1.01

1.10

u/l

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

118

3.81

14.57

1.0

1.3

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

12.82

13.91

1.2

—

(3019150) Specific gravity of Urine by Refractometry

416

2905

1.61

13.90

7.4

3.6

1.02

1.55

kg/l

0.50

343

1876

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

127

3.63

13.86

2.1

2.6

21.70

39.51

iu/ml

—

(40768806) Pleura Pathology biopsy report

4.06

13.40

1.4

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

121

3.63

13.31

1.3

1.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

123

3.57

12.99

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

10.16

12.99

2.2

2.4

0.62

0.61

mmol/l

0.24

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

5.08

12.92

1.4

1.2

583.33

1063.64

titre

—

(3000060) B lymphocytes [#/volume] in Blood

11.67

12.82

1.7

4.0

0.14

0.21

e9/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

740

5951

1.50

12.67

3.5

2.6

—

estimate

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

121

3.55

12.56

1.2

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

133

3.38

12.24

1.7

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

4.66

12.15

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

134

3.36

12.10

1.7

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

3.87

11.95

1.4

1.3

54465.58

92448.85

e6/l

0.23

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

4.59

11.91

1.4

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

5.42

11.84

2.8

2.0

62.74

67.86

ug/l

0.08

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

131

3.35

11.83

1.7

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

107

3.62

11.77

1.3

2.0

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1293

11878

1.86

11.59

29.6

12.4

82.39

82.95

ml/min/173m2

0.38

1238

10871

(40768441) Liver Pathology biopsy report

3.95

11.59

1.2

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

4.33

11.51

1.4

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

251

2.62

11.29

1.3

1.7

17.06

41.60

e6/l

0.48

186

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.49

11.22

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

114

576

2.06

11.21

1.8

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

4.78

11.20

1.3

2.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

5.59

11.18

1.0

1.1

251.47

169.19

iu/ml

0.36

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

5.59

11.18

1.0

1.1

518.14

720.78

ng/l

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

160

909

1.86

11.18

3.9

2.3

60.81

70.73

ml/min/173m2

2.38

382

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

259

2.58

11.11

1.4

1.7

1239.00

1673.76

e6/l

0.12

206

(3047007) Chlamydophila sp Ab [Presence] in Serum

213

2.75

11.05

1.3

1.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

4.31

11.04

2.0

1.3

26.01

27.20

0.06

(4035726) Immunohistochemistry procedure

186

1111

1.77

11.02

1.5

1.4

—

(3045788) Cell count panel - Pleural fluid

3.77

10.89

1.4

1.3

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

203

1248

1.73

10.87

7.3

6.6

4.90

5.11

kpa

2.33

194

1207

(3019977) pH of Arterial blood

202

1243

1.73

10.78

7.4

6.6

7.43

7.42

2.57

106

652

(3016502) Oxygen saturation in Arterial blood

181

1081

1.77

10.72

7.2

7.0

94.87

95.82

0.72

176

1048

(3027801) Oxygen [Partial pressure] in Arterial blood

202

1248

1.72

10.62

7.3

6.6

11.68

12.93

kpa

3.11

194

1208

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.96

10.60

1.2

1.0

—

(21494434) Karyotype in Bone marrow

3.69

10.55

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

4.12

10.44

1.1

1.3

22.12

24.91

umol/l

0.18

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

334

2348

1.55

10.41

1.7

1.6

65979832.84

55736474.71

pmol/l

0.08

291

1970

(3008898) HLA-B27 [Presence]

408

2.21

10.36

1.0

1.1

—

(3042733) HLA Ab [Presence] in Serum

10.12

10.02

5.9

3.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1272

11723

1.72

10.01

6.7

4.3

1.92

1.84

mu/l

1.61

1220

10909

(3042631) Mycobacterium sp identified in Specimen

130

3.14

9.95

2.8

2.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

125

3.18

9.93

1.7

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

4.42

9.82

1.8

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

4.42

9.82

1.8

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

126

3.15

9.80

1.7

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

101

3.42

9.76

1.6

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

101

3.42

9.76

1.6

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

101

3.42

9.76

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

127

3.13

9.68

1.7

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

4.22

9.65

1.1

0.36

0.08

nmol/l

—

(3003396) Base excess in Arterial blood by calculation

196

1232

1.68

9.63

7.3

6.6

0.54

0.86

mmol/l

0.40

165

1029

(3010838) Calcium [Moles/time] in 24 hour Urine

235

2.53

9.61

1.8

1.9

4.26

4.95

mmol/24h

0.84

212

(3003181) Sodium [Moles/volume] in Urine

195

2.67

9.50

1.4

47.64

58.62

mmol/l

1.20

156

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

250

2.46

9.38

5.6

3.0

9.87

7.97

pmol/l

0.79

250

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.72

9.31

1.5

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.72

9.31

1.5

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.72

9.31

1.5

1.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

13.76

9.18

1.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

190

1201

1.67

9.13

2.9

2.2

38.62

40.54

u/l

0.16

162

997

(40768804) Tissue Pathology biopsy report

657

5389

1.40

8.91

2.4

2.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

258

2.38

8.78

1.1

18.83

17.44

au/ml

0.08

(3019550) Sodium [Moles/volume] in Serum or Plasma

1333

12537

1.84

8.62

31.6

15.1

139.13

139.77

mmol/l

14.86

1318

12283

(3003327) Ova and parasites identified in Stool by Light microscopy

448

2.03

8.51

2.2

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

4.49

8.38

1.1

1.0

1638.93

1315.60

miu/ml

0.62

(3023419) Bacteria identified in Sputum by Culture

144

2.83

8.37

2.6

2.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1334

12565

1.82

8.35

32.3

15.2

3.93

3.94

mmol/l

0.55

1315

12271

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

123

2.98

8.27

2.6

4.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

6.53

8.19

1.5

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

6.53

8.19

1.1

1.5

—

(3022621) pH of Urine by Test strip

165

1034

1.67

8.18

3.4

2.4

6.14

6.09

0.28

693

(3000012) Reticulocyte production index

124

2.95

8.16

2.7

1.9

0.97

0.92

0.22

(21494890) Protein electrophoresis panel - 24 hour Urine

108

3.10

8.16

1.4

1.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.78

8.12

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

176

2.61

8.05

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

136

2.84

8.05

1.1

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

10.09

8.03

1.1

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.54

7.66

1.9

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.54

7.66

1.9

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

8.08

7.60

1.1

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

336

2.11

7.54

1.3

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

10.09

7.53

1.1

1.0

8.50

7.31

mg/g

0.20

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

13.43

7.39

1.8

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

346

2.08

7.36

1.3

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.64

7.31

1.1

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.87

7.30

1.1

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

15.83

7.23

1.1

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

180

2.49

7.21

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

4.52

7.18

1.1

91.63

97.86

—

(3023410) Appearance of Cerebral spinal fluid

117

2.86

7.14

1.4

2.1

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

148

934

1.65

7.14

1.7

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

101

3.01

7.10

1.1

106.47

106.32

pmol/l

0.01

101

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

324

2.09

7.08

1.1

0.78

3.82

eliau/ml

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

7.02

7.00

1.1

1.2

1.85

61.47

ug/l

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

132

813

1.69

6.98

1.4

1.2

94.93

80.56

u/ml

0.24

259

(3006184) Hemoglobin [Mass/volume] in Capillary blood

246

2.24

6.98

1.9

2.3

131.14

127.66

g/l

0.49

193

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

4.40

6.97

1.1

1.0

89.38

93.55

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

215

1492

1.52

6.90

4.9

4.7

34.37

32.45

1.70

162

967

(1761868) Lipid panel - Serum or Plasma

411

5111

0.73

6.81

2.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

132

2.69

6.77

3.0

2.2

40.25

23.43

mg/l

0.60

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

16.77

6.75

1.8

1.2

—

(40761536) Microorganisms panel - Urine sediment

142

900

1.64

6.73

11.1

3.6

—

(3000034) Microalbumin [Mass/volume] in Urine

3.17

6.73

4.5

2.5

89.42

13.76

mg/l

0.86

(3024471) HLA-A [Type]

7.21

6.71

1.0

—

(3025941) Bacteria identified in Stool by Culture

113

677

1.73

6.62

1.3

1.2

—

(3024263) Appearance of Synovial fluid

4.18

6.56

2.1

1.5

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

8.73

6.55

1.0

1.1

—

(3024932) HLA-DR beta [Type]

6.88

6.52

1.0

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

6.21

6.47

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.72

6.46

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

5.54

6.30

1.1

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

+∞

6.25

6.8

0.0

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

+∞

6.25

7.0

0.0

35.93

—

mg/l

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

3.32

6.15

1.2

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

3.71

5.93

1.2

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

15.08

5.90

18.0

22.3

5.17

5.05

mmol/l

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

5.05

5.88

1.4

2.7

176.94

134.00

1.33

(3027456) Digoxin [Moles/volume] in Serum or Plasma

192

2.28

5.87

3.7

3.4

0.83

0.82

nmol/l

0.05

163

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.37

5.73

1.2

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.77

5.61

1.7

1.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

10.06

5.53

1.2

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

5.88

5.53

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

217

2.16

5.52

1.3

23.11

23.38

u/l

0.02

181

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

334

1.93

5.52

1.3

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

946

8545

1.31

5.50

4.3

3.1

56.36

41.44

u/l

2.63

910

8065

(1616796) Gas panel - Central venous blood

185

2.25

5.48

4.6

3.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

3.49

5.46

1.2

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

6.24

5.39

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

5.64

5.38

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

268

2.01

5.32

2.8

2.6

1.18

1.53

mmol/l

4.82

260

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

4.75

5.30

1.3

1.1

118.75

106.07

0.91

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

182

2.23

5.25

2.6

2.3

91.62

68.16

ug/min

0.25

101

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

923

8347

1.29

5.11

3.8

3.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

337

1.88

5.07

1.3

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

172

2.24

5.06

1.6

1.3

—

(3017569) Oxygen content in Arterial blood

3.43

5.03

3.4

2.3

16.05

16.65

0.27

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

10.05

5.03

1.1

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1359

13082

1.67

5.00

28.6

9.8

24.99

24.50

u/l

0.60

1349

12720

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1365

13155

1.70

5.00

41.2

16.3

78.02

71.23

umol/l

6.52

1355

12994

(4024509) Urine culture

581

1.66

4.96

2.6

1.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

100

2.63

4.91

4.5

2.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

2.80

4.89

1.5

78.96

74.89

umol/l

0.25

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

9.05

4.78

1.1

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

5.24

4.77

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

4.45

4.75

1.1

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

596

1.64

4.74

2.4

2.2

—

(4015189) Microbial culture of sputum

6.15

4.60

2.6

3.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

2.70

4.59

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

14.06

4.58

1.3

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

103

1544

0.64

4.55

1.6

1.9

3.20

3.34

ratio

0.56

1179

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.41

4.44

1.1

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

345

1.80

4.43

1.3

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

112

2.44

4.40

1.2

1.1

18.72

16.42

u/ml

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

246

1.94

4.34

3.0

3.5

581.10

1642.90

u/ml

0.44

226

(3025130) Human papilloma virus identified in Specimen

289

1.87

4.33

2.1

1.9

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

6.29

4.29

1.1

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.83

4.18

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

176

1297

1.41

4.12

3.1

4.5

15.20

20.37

ug/l

0.26

134

1020

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

155

1117

1.43

4.11

4.0

2.9

—

(3014007) Fractional oxyhemoglobin in Arterial blood

109

735

1.52

4.03

8.8

8.0

92.18

94.00

1.00

109

730

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.03

4.00

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.69

4.00

1.8

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.69

4.00

1.8

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

177

2.06

3.97

1.2

1.0

3.80

2.70

eliau/ml

—

(40768795) Lymph node Pathology biopsy report

138

2.20

3.91

1.3

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

2.90

3.90

1.1

90.00

86.38

u/l

0.09

(3038515) Glucose [Moles/volume] in Venous blood

221

1.93

3.85

3.0

2.6

6.71

7.02

mmol/l

0.42

216

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

6.03

3.82

2.4

1.5

—

(3012501) Base excess in Blood by calculation

173

2.05

3.81

4.7

3.0

2.97

2.51

mmol/l

0.43

108

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1171

0.63

3.81

1.4

1.7

3.21

3.49

mmol/l

1.48

810

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

2.86

3.80

1.1

18.59

27.62

u/l

0.59

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1220

11606

1.33

3.76

6.7

5.5

38.14

38.03

mmol/mol

0.13

1171

10913

(3040151) Glucose [Moles/volume] in Capillary blood

102

2.38

3.75

2.7

3.2

6.81

6.37

mmol/l

0.34

(3032773) Endomysium IgG Ab [Titer] in Serum

121

2.25

3.75

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

320

2620

1.28

3.69

1.7

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

5.65

3.66

1.2

3.0

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

6.18

3.50

4.9

1.5

1.75

3.00

—

(3035637) Corticotropin [Mass/volume] in Plasma

139

2.11

3.45

1.4

1.5

29.17

20.63

ng/l

0.59

139

(3014271) Vancomycin [Susceptibility]

3.11

3.37

3.8

2.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.03

3.36

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.73

3.32

2.0

1.7

—

(3049717) Cytology report of Urine Cyto stain

332

1.68

3.26

2.1

2.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

106

747

1.45

3.21

1.0

—

(21494755) Public health laboratory ask at order entry panel

1300

0.68

3.19

1.2

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

104

2.23

3.16

3.2

2.6

17.98

31.06

mg/l

1.19

(3044242) Glucose [Moles/volume] in Arterial blood

2.82

3.09

3.8

2.1

6.14

7.85

mmol/l

2.07

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.02

3.08

1.3

1.7

1.19

mmol/l

—

(3032057) Clostridioides difficile [Presence] in Stool

5.02

3.05

1.9

2.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

5.86

3.02

1.3

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

3.57

2.99

1.1

1.2

31.32

38.12

g/l

—

(3035880) pH of Pleural fluid

2.84

2.92

1.1

1.0

7.48

7.38

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.26

2.87

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

6.69

2.87

1.0

5.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

531

1.50

2.83

1.5

1.6

30.51

14.17

u/ml

—

133

(3000330) Specific gravity of Urine by Test strip

600

1.46

2.77

6.5

3.2

1.02

ratio

0.53

542

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

452

1.53

2.77

3.4

3.5

673.38

1021.25

u/ml

0.21

396

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

104

2.13

2.75

1.9

1.7

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

8.36

2.75

1.0

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

8.36

2.75

1.4

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.02

2.69

1.4

1.5

—

(3026726) Creatinine [Moles/volume] in Specimen

7.16

2.55

2.8

2.4

308.80

469.00

umol/l

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.47

2.54

1.2

1.4

—

(3050794) Legionella sp Ab [Presence] in Serum

5.47

2.54

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.47

2.54

1.2

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

157

1.86

2.53

1.0

1.1

—

(3004451) EKG impression Narrative

2.51

2.53

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

753

0.64

2.50

1.6

1.5

990.52

1021.09

mu/l

0.10

613

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

596

5386

1.18

2.49

2.0

1.8

1.34

1.33

mmol/l

0.04

518

4598

(40757373) Influenza virus identified in Isolate

3.48

2.48

2.0

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.47

2.45

1.6

1.5

1.44

1.82

u/field

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.91

2.41

3.7

4.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1244

12012

1.26

2.38

5.3

4.8

5.58

5.77

mmol/l

6.98

1179

11117

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.27

2.37

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.27

2.34

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.10

2.33

1.5

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

119

1.95

2.31

1.2

—

(3008295) Osmolality of Serum or Plasma

119

1.95

2.31

1.3

1.7

269.81

278.78

mosm/kgh2o

0.83

(3004446) Plasmodium sp identified in Blood by Light microscopy

4.63

2.27

2.3

2.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.90

2.25

3.4

1.8

—

(4211845) Urine protein measurement

2.35

2.22

4.8

2.4

—

(3051611) Lipemic interference index of Serum or Plasma

100

2.01

2.21

5.5

3.4

15.23

11.86

index

0.67

(40765096) Chromosome analysis panel by Banding

2.87

2.21

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

681

0.65

2.17

1.5

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.30

2.15

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.01

2.15

1.6

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

260

1.59

2.11

5.6

4.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

160

1.76

2.10

1.5

1.3

0.50

0.29

nmol/l

0.29

126

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

5.01

2.07

1.0

1.1

—

0.10

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.01

2.07

1.2

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

500

1.42

2.06

1.3

245.13

228.16

miu/ml

0.13

260

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.51

2.05

3.3

1.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.01

2.04

1.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2.64

2.00

1.0

2.2

35.86

41.40

g/l

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

462

1.43

1.98

1.7

0.51

0.34

mg/l

0.80

211

(3036071) Salmonella sp Ab [Titer] in Serum

2.57

1.94

1.3

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.32

1.88

1.3

166.00

154.67

mmol/24h

0.18

(3009214) Lutropin [Units/volume] in Serum or Plasma

326

1.49

1.85

1.5

1.4

10.57

10.99

u/l

0.06

260

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.18

1.82

1.2

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.27

1.81

3.6

2.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

231

1.57

1.80

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.05

1.80

2.1

3.7

5.00

4.79

kpa

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.05

1.80

1.1

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.05

1.80

2.1

3.7

9.83

10.27

kpa

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

2.77

1.79

1.4

1.1

42.50

67.71

—

(3002523) Influenza virus A Ag [Presence] in Specimen

232

1.57

1.77

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1.92

1.70

1.6

2.0

1.29

2.00

u/field

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

525

0.66

1.68

1.0

1.2

1.58

1.59

g/l

0.07

525

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1200

11635

1.19

1.67

4.7

4.0

1.25

1.24

mmol/l

0.07

1134

10766

(3004716) Salmonella sp identified in Stool by Organism specific culture

661

1.32

1.66

1.7

1.4

—

(3051651) Icteric interference index of Serum or Plasma

2.07

1.60

7.1

3.5

0.38

0.81

index

1.83

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

128

1557

0.80

1.57

1.8

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1258

12262

1.20

1.57

5.4

4.7

1.50

1.53

mmol/l

1.55

1192

11459

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

537

0.68

1.52

1.1

1.2

0.82

0.89

g/l

0.92

537

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

317

1.43

1.49

2.0

1.7

7.80

2.73

iu/l

1.00

114

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

155

1.62

1.47

1.4

1.3

—

nmol/l

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

414

0.65

1.46

1.4

0.94

0.96

ratio

0.11

255

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

414

0.65

1.46

1.4

1.19

1.18

ratio

0.02

255

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

414

0.65

1.46

1.4

1.24

1.14

ratio

0.17

255

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.73

1.43

1.2

1.1

0.04

0.02

u/ml

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

166

1408

1.20

1.42

1.5

1.8

1.53

1.40

1.06

143

1258

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

410

0.65

1.41

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1261

12319

1.19

1.39

5.5

4.7

4.48

4.79

mmol/l

25.65

1199

11576

(3050129) First trimester maternal screen panel - Serum or Plasma

491

0.69

1.39

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

2.95

1.36

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

488

0.69

1.35

1.0

1.1

0.50

0.63

ratio

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

357

0.64

1.34

1.5

—

(3006462) Nitrate [Presence] in Urine

2.05

1.33

5.8

2.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.29

1.27

1.6

3.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.11

1.18

3.5

3.8

0.56

1.57

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

345

0.66

1.17

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1273

12483

1.17

1.13

6.0

5.4

2.54

2.81

mmol/l

29.83

1205

11696

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

157

1358

1.18

1.11

6.8

5.9

—

(3022689) Creatine [Moles/volume] in Urine

2.26

1.10

3.1

1.3

7.40

7.79

mmol/l

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

194

1.45

1.07

2.1

2.6

7.10

4.90

umol/l

0.51

138

(44806420) Estimation of glomerular filtration rate

158

0.57

0.98

2.9

2.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

548

0.76

0.98

1.5

1.7

6.62

4.27

mg/l

0.55

411

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

354

0.70

0.98

1.6

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.00

0.97

0.0

1.1

—

267.50

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

107

908

1.19

0.97

1.4

36.50

29.50

iu/l

1.12

787

(3014133) Dog dander IgE Ab [Units/volume] in Serum

235

0.63

0.96

1.1

11.75

3.70

u/ml

—

111

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.23

0.93

1.5

1.1

—

(4034850) Laboratory test

406

0.73

0.91

33.0

8.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

266

0.67

0.89

1.1

0.76

1.25

u/ml

—

130

(3019832) Treponema pallidum Ab [Presence] in Serum

161

1425

1.15

0.88

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

229

1.36

0.87

1.3

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

255

1.34

0.87

5.8

3.4

29.70

22.71

mg/l

0.76

169

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

310

0.71

0.86

1.7

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.61

0.81

1.2

1.6

4.41

7.90

ug/l

1.51

(3047189) Immunofixation for 24 hour Urine

1.73

0.79

1.2

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.59

0.78

2.7

1.6

112.32

90.48

ng/l

0.28

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.70

0.75

2.2

2.7

800.46

19.98

ug/l

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

181

1634

1.12

0.75

4.5

5.2

1.79

2.44

ug/l

1.40

159

1468

(3043410) Blood group antigens tested for on Red Blood Cells

2.09

0.74

2.0

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.09

0.74

1.4

1.1

481.40

349.20

pmol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

309

2872

1.10

0.74

1.8

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.85

0.73

1.0

43.99

28.28

iu/ml

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

180

1628

1.12

0.73

1.8

2.2

—

(4281824) Cell count and differential, peritoneal fluid

195

0.66

0.72

1.4

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

583

1.19

0.70

1.8

2.1

8485.30

6825.87

u/l

0.11

239

(4094501) Cardiovascular stress test using bicycle ergometer

330

0.75

0.69

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

212

0.70

0.63

1.2

1.1

1.87

3.75

u/ml

—

(44813793) Dust mix specific IgE antibody measurement

1.50

0.63

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

336

0.77

0.63

1.3

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

223

0.71

0.63

1.3

1.7

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

408

1.21

0.60

1.4

1.5

153.69

167.24

pmol/l

0.09

400

(3025018) Bordetella pertussis Ab [Titer] in Serum

105

1.43

0.60

1.1

1.2

—

(3005570) Glucose [Moles/volume] in Urine

114

1.41

0.59

2.5

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

940

0.88

0.54

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

327

0.79

0.53

1.1

0.85

1.88

u/ml

0.96

180

(3008401) Mugwort IgE Ab [Units/volume] in Serum

268

0.78

0.49

1.1

1.48

1.37

u/ml

—

117

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

159

1473

1.09

0.45

1.8

2.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

535

1.15

0.45

1.5

1.6

241.85

298.26

mu/l

1.37

488

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.41

0.0

1.3

—

5.97

—

(3006653) Thiamine [Moles/volume] in Blood

1.34

0.40

1.3

1.4

119.63

136.87

nmol/l

—

(1002224) Polysomnography panel

619

1.12

0.38

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

257

0.81

0.37

1.3

1.5

55.10

57.39

ug/l

0.19

257

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.35

0.37

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

535

1.13

0.36

2.9

2.2

11.85

11.72

nmol/l

0.04

495

(3003888) Timothy IgE Ab [Units/volume] in Serum

277

0.83

0.35

1.1

5.32

4.30

u/ml

0.12

147

(3028707) Methadone [Presence] in Urine by Screen method

209

1.20

0.34

1.6

1.8

—

(4198724) Urine methamphetamine measurement

1.31

0.33

1.0

1.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.31

0.30

1.1

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

910

1.08

0.30

2.0

1.8

—

(3011288) Drugs identified in Urine by Screen method Nominal

345

0.87

0.29

1.9

2.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

206

0.82

0.29

1.1

1.0

0.07

0.26

u/ml

—

(3002256) Pathology report gross observation

189

1801

1.06

0.28

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

0.69

0.26

1.0

—

0.23

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1366

13602

1.08

0.25

51.0

19.5

91.60

90.80

7.83

1359

13473

(3007461) Platelets [#/volume] in Blood

1366

13602

1.08

0.25

51.3

19.5

252.26

258.51

e9/l

2.67

1352

13335

(3035941) MCH [Entitic mass]

1366

13603

1.08

0.24

50.9

19.4

30.26

30.19

0.73

1359

13474

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1366

13603

1.08

0.24

51.8

19.8

39.01

40.04

14.50

1358

13467

(3010813) Leukocytes [#/volume] in Blood

1366

13605

1.08

0.23

51.3

19.6

6.41

6.64

e9/l

2.37

1350

13285

(3026361) Erythrocytes [#/volume] in Blood

1366

13605

1.08

0.23

51.2

19.5

4.30

4.47

e12/l

31.50

1348

13294

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.22

0.22

1.0

2.2

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

0.21

0.0

5.6

—

8.50

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.21

0.0

2.8

—

40.20

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.1

—

1.32

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

220

1.14

0.21

1.8

1.7

0.93

0.89

nmol/l

0.09

192

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.16

0.21

1.0

1.2

111.94

148.77

pmol/l

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3003694) ABO and Rh group [Type] in Blood

387

3779

1.03

0.20

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

106

1005

1.06

0.20

2.8

3.1

0.76

0.75

ug/l

0.03

627

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.5

—

48.14

—

(3000963) Hemoglobin [Mass/volume] in Blood

1366

13611

1.07

0.20

51.6

19.6

129.04

133.97

g/l

34.77

1358

13479

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

176

0.85

0.20

1.2

—

(4146454) Self-monitoring of blood glucose

101

1.19

0.16

4.2

2.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.78

0.15

1.2

15.50

8.84

mm/h

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.08

0.14

1.6

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

0.79

0.14

1.0

1.7

0.60

1.33

promille

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

655

1.06

0.14

1.7

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

110

0.82

0.13

1.6

1.7

7.10

7.96

mmol/l

—

105

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

580

0.95

0.12

1.5

—

(3020650) Glucose [Presence] in Urine

1.14

0.10

1.6

1.5

0.00

estimate

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.11

0.09

1.2

1.7

0.42

0.46

e9/l

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.09

0.09

1.6

1.8

67.66

75.61

nmol/24h

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

159

1557

1.02

0.08

1.6

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

136

1329

1.03

0.08

3.4

4.3

23.03

21.04

0.68

617

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.05

0.08

1.2

1.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.09

0.08

1.0

1.2

406.14

440.42

u/l

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

460

1.04

0.08

1.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.86

0.07

1.3

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.03

0.07

1.2

1.5

—

(40768800) Prostate Pathology biopsy report

105

0.86

0.06

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

247

1.05

0.05

1.3

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

112

1103

1.02

0.04

2.2

2.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

392

0.97

0.04

1.6

1.4

—

(3027944) Amphetamines [Presence] in Urine

501

0.98

0.03

1.5

1.7

—

(3028300) Cannabinoids [Presence] in Urine

510

1.02

0.02

1.5

1.7

—

(3006270) Folate [Moles/volume] in Blood

1.08

0.02

1.4

1.1

351.07

395.82

nmol/l

—

(3000764) Benzodiazepines [Presence] in Urine

502

1.02

0.01

1.5

1.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

194

1.03

0.00

1.3

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

156

1.03

0.00

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

111

0.99

0.00

1.3

1.5

11.95

7.86

mmol/l

0.60

106

(40768793) Breast Pathology biopsy report

448

1.00

0.00

1.4

1.3

—

(3016879) Cocaine [Presence] in Urine

463

0.99

0.00

1.5

1.7

—

(3027008) Opiates [Presence] in Urine

505

0.99

0.00

1.5

1.7

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.00

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.8

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

-0.00

0.0

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.92

-0.00

1.5

1.2

—

1953.34

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

8.1

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

110

1.00

-0.00

1.2

1.5

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.94

-0.00

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

64.33

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

3.0

—

199.60

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.95

-0.00

1.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

317.67

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.7

—

298.43

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

0.93

-0.00

1.0

—

0.40

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: SLE_FG – SLE (Finngen)

GWS hits: 11

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

SLE (Finngen)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for SLE (Finngen) (SLE_FG)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints